86
Marex Spectron Group Limited Annual Report and Financial Statements Year ended 31 December 2016 Registration Number 05613060

Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Embed Size (px)

Citation preview

Page 1: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

Annual Report and Financial Statements

Year ended 31 December 2016

Registration Number 05613060

Page 2: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

1

TABLE OF CONTENTS

Company Information ................................................................................................................................................... 2

Directors’ Report .......................................................................................................................................................... 3

Directors’ Responsibilities Statement........................................................................................................................... 8

Strategic Report ............................................................................................................................................................ 9

Independent Auditor’s Report .................................................................................................................................... 25

Consolidated Income Statement ................................................................................................................................. 27

Consolidated Statement of Other Comprehensive Income ......................................................................................... 27

Statements of Financial Position ................................................................................................................................ 28

Statement of the Changes in Equity and Movements in Reserves ............................................................................. 30

Cash Flow Statements ................................................................................................................................................ 31

Notes to the Financial Statements............................................................................................................................... 33

Page 3: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

2

COMPANY INFORMATION

Country of Incorporation England and Wales

Legal Form Private limited company

Directors S J N Heale (Chairman)

I T Lowitt (Chief Executive Officer)

J H Baldwin

J C Cohen

Lord S Fink

D A Hallgarten

J M Isaacs CBE

P Kadas

J E Nader

R B Nagioff

V Pignatti-Morano Campori

S H Sparke

C R Stent

S Van Den Born

Company Secretary D A Harvey

Registered Office 155 Bishopsgate, London, EC2M 3TQ

Auditors Deloitte LLP

Hill House, 1 Little New Street, London, EC4A 3TR

Bankers Lloyds Bank plc

25 Gresham Street, London, EC2V 7HN

Bank Leumi (UK) plc

20 Stratford Place, London, W1C 1BG

HSBC Bank plc

Level 19, 8 Canada Square, London, E14 5HQ

Barclays Bank plc

1 Churchill Place, London, E13 5BH

Page 4: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

3

DIRECTORS’ REPORT

The directors present their report and audited consolidated financial statements of Marex Spectron Group Limited

(‘Marex Spectron’, ‘the Group’ or ‘the firm’) and the standalone financial statements for Marex Spectron Group

Limited (‘the Company’) for the year ended 31 December 2016.

About Marex Spectron

Marex Spectron is a leading independent global commodities brokerage headquartered in London with a global

network spanning Asia and North America, with dominant market shares in many major agricultural, metal and

energy products. The firm has a broad range of clients including commodity producers and consumers, banks,

hedge funds, asset managers, brokers, commodity trading advisors and professional traders.

We are members of the London Metal Exchange (‘the LME’), where we are a Category 1 Member and Ring

Dealer; the CME Group of exchanges (‘the CME’), the Intercontinental Exchange group of exchanges (‘ICE’) and

many others.

We are regulated in the UK by the Financial Conduct Authority (‘the FCA’, which also regulates our Group under

consolidated supervision), in the US by the National Futures Association (‘the NFA’) and the US Commodities

Futures Trading Commission (‘the CFTC’), in Hong Kong by the Securities and Futures Commission (‘the SFC’),

and in Singapore by the Monetary Authority of Singapore (‘the MAS’) and the International Exchange Singapore

(‘the IES’).

We believe Marex Spectron is the world’s leading commodity broker because of our unique competitive attributes:

1. our unrivalled breadth of commodity market coverage across Energy, Metals and Agricultural products;

2. extensive depth of services across Commodity Brokerage in each market segment and Financial Futures

and Options;

3. a diversified client base consisting of blue chip commodity producers / consumers as well as leading

financial players in our market;

4. an efficient and scalable platform; and

5. leading proprietary technology, data and analytic offerings.

While other competitors might match our offering in one specific commodity category, we are unique in being top

ranked across Metals (number 1 on LME), Energy (top 3 in all major products globally) and Agricultural (number

1 in global softs options).

In Energy, we provide agency brokerage across over-the-counter (‘OTC’) and Exchange-Cleared Contracts with a

focus on Fuel Oil, Natural Gas, Iron Ore, Coal, Crude, Light Ends, Environmental and Freight.

In Metals, we provide brokerage and market making services for base and precious metals (Aluminium, Copper,

Nickel, Zinc, Lead and Gold). We are the leading Ring Dealer on the LME.

In Agriculture, we are primarily a broker, but also provide market making in specific option products (Cocoa,

Coffee, Sugar and European Grains).

Around 60% of our commissions are generated by commodity producers / consumers and 40% by financial

companies who participate in our markets. We do substantial business with essentially all the largest participants in

commodities.

We are deeply embedded in the global commodity market infrastructure, with 35 exchanges in our connectivity

networks. We clear over 150 million contracts a year on exchange and execute over 26 million trades a year for

our clients. We operate out of 11 offices globally with 500 employees in Europe, North America and Asia.

Increasingly, we are providing our clients not just with access to market liquidity, and to management of order flow

(screen, voice and Direct Market Access), but also data and analysis. Funds and money managers are ever more

reliant on quantitative data to support trading and execution decisions. To fill the gap in the market resulting from

banks scaling back and attract institutional clients, Marex Spectron has invested in ‘Intelligence’ (including

proprietary models) and 'Content' (quotes, reports, research) which provide advantage over traditional client

technology providers, and enables us to differentiate ourselves from brokerage competitors. Our NEON platform

in Metals and Nanolytics data is a leader in the industry.

Page 5: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

DIRECTORS’ REPORT (CONTINUED)

4

Chief Executive Officer’s Review

2016 was a record year for the firm, as we maintained our positive earnings trajectory delivering profits before tax

(‘PBT’) of $27 million, up from $17.6 million in 2015. We have now shown improvement in profitability over a

four-year period.

While over the past few years our earning improvement has been driven largely by exiting unprofitable activities

and resource optimisation, in 2016 we effected an important shift in focus, with an emphasis on finding additional

ways to grow our business – and increasing our earnings – through the addition of new talent, new products and the

expansion of our geographic footprint.

This focus on growth is evident in all our geographies, and across all our products:

▪ in North America, we opened a new office in Calgary and hired a leading Canadian physical oil team,

as well as built the systems necessary for them to begin broking in January 2017. We hired a leading

Light Ends broker in the US and we also entered the US Power business;

▪ in Asia, we launched a Metals trading capability in Singapore – a move that reflects the importance of

the Asian markets and the time zone to our global business – and we built-out a leading Light Ends

brokerage business;

▪ in Europe, we built a team to broker Clean Freight in London and developed our Energy Clearing

capabilities. In Financial Futures and Options, we hired a high quality team in anticipation of an

improving environment for this business;

▪ in our Metals business, we are building out an OTC offering, developing an alternative marketplace to

LME’s electronic platform, and leveraging our new NEON trading platform to win electronic business;

▪ in Agriculture, we restructured the grains trading desk to improve risk adjusted returns, rolled out a

new investment product to select clients, and expanded trading in the US; and

▪ we operationally launched our Nanolytics quant commodities fund. Nanolytics utilises Marex

Spectron’s institutional scale infrastructure to process enormous quantities of publically available data,

covering 24 commodity markets to deliver insight into underlying demand-supply balances which

indicate likely future price movement.

To deliver many of these initiatives, we have been able to leverage off the capabilities we have built in our Support

and Control team.

This was ably demonstrated at the Canada launch, where in two months we developed, essentially from scratch, an

interactive electronic marketplace that allows users to view and trade over 500 separate products.

To support the new Energy Clearing business, we joined a new exchange and clearing house (that supports five

exchanges) and developed a straight through processing (‘STP’) solution, all of which was achieved in just three

months.

Building a strong Marex Spectron culture, based on our values of respect for clients, personal integrity,

collaboration, developing our people and adaptability, is an important management priority. This underpins our

commitment to a world class control environment, excellent risk management and great client service. We know

that our people are the basis of our competitive advantage and we have developed an environment where ambitious,

hardworking and talented people choose to build their careers and are excited to work.

To help us further develop our business, we increased on liquidity resources, adding Barclays as the third bank to

our Working Capital Facility, and strengthened our relationships with a core set of banks.

We are proud of what we have accomplished over the past year in challenging market conditions and look forward

to 2017. We will continue to be prudent and sensible, maintaining our strong liquidity and capital profile,

alongside a lean cost structure, and we anticipate revenue growth from our various initiatives. We are winning

clients, adding to our offerings and gaining market share, all of which is reflecting our increasing competitiveness.

As we look to build a great firm, I would like to thank the employees at Marex Spectron for their effort and hard

work.

Page 6: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

DIRECTORS’ REPORT (CONTINUED)

5

Conclusion and future developments

In 2016, Marex Spectron continued its strong earnings growth achieving record levels of profit. Importantly, in

2016, the firm invested broadly across products and geographies to increase diversification and provide a strong

platform for future growth.

While the Group is well positioned to benefit from improving commodity markets, it is not reliant on such

improvement; the organisation has worked hard to increase its competitiveness, in particular improving content,

market intelligence and technology capabilities. The firm has increased market share, attracted new clients and

hired some of the best talent in the world. The future is always uncertain but management is confident that Marex

Spectron is well placed to continue its positive growth.

The directors, in preparing this strategic report, have complied with s414C of the Companies Act 2006.

I T Lowitt

Chief Executive Officer

29 March 2017

Directors

The following directors have held office throughout the year and to the date of this report, except where noted:

Appointed Resigned

S J N Heale (Chairman)

I T Lowitt (Chief Executive Officer)

J H Baldwin 1 March 2016

J C Cohen

Lord S Fink

D A Hallgarten

J M Isaacs CBE

P Kadas

J E Nader 15 February 2016

R B Nagioff

V Pignatti-Morano Campori

S H Sparke

C R Stent

P M Sugarman 15 February 2016

S Van Den Born 1 March 2016

J P Wall 8 January 2016

Indemnity of directors

Each director is indemnified out of the assets of the Group against all costs, charges, losses and liabilities incurred

by them in the proper exercise of their duties. Directors who have resigned during the year also benefit from the

same indemnity arrangement. In addition, the directors are covered by an insurance policy.

afayyaz
Stamp
Page 7: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

DIRECTORS’ REPORT (CONTINUED)

6

Directors’ statement as to disclosure of information to the Auditor

Each of the persons, who is a director at the date of approval of this report, confirms that:

▪ so far as he / she is aware, there is no relevant audit information of which the Group’s auditor is

unaware; and

▪ that he / she has taken all the steps that he / she ought to have taken as a director in order to make

himself / herself aware of any relevant audit information and to establish that the Group’s auditor is

aware of that information.

This confirmation is given and should be interpreted in accordance with the provisions of s418 of the Companies

Act 2006.

Charitable and political contributions

Marex Spectron maintains a $100,000 per annum fund to support employees in their charitable fundraising

activities. It does this by donating 50% of the sum raised by the employee to the chosen charities. In order to

ensure that the fund can be accessed by as many employees as possible, donations from the company are capped at

$2,500 per fundraising event. The total charitable donations from this programme were $35,792 during the year

ended 31 December 2016 (2015: $28,995).

No contributions were made for political purposes during the year (2015: $nil).

Foreign exchange

The following foreign exchange rates have been used in the preparation of these financial statements:

2016 2015

Average

Rate

Year-end

Rate

Average

Rate

Year-end

Rate

GBP / USD 1.3554 1.2345 1.5248 1.4738

USD / EUR 1.1070 1.0524 1.1031 1.0855

Going concern

After reviewing the Group and Company’s annual budget, liquidity requirements, plans and financial arrangements

the directors are satisfied that the Group and Company have adequate resources to continue to operate for the

foreseeable future and for at least 12 months from the date of signing of the balance sheet and confirm that the

Group and Company are a going concern. For this reason they continue to adopt the going concern basis in the

preparation of these financial statements.

Events after the reporting period

Events since the statement of financial position date are disclosed in note 34.

Overseas branches

The Group has branches in the US, Canada, Germany, and Norway.

Dividends

During the year, Marex Spectron Group Limited declared and paid a dividend of $20 million (2015: $ nil).

Financial risk management

Financial risk management objectives are included in the strategic report.

Future developments

Future developments are included in the strategic report.

Page 8: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

DIRECTORS’ REPORT (CONTINUED)

7

Suppliers

Terms and conditions for business transactions are agreed individually with suppliers. Payment is then made on

these terms subject to the terms and conditions being met by the suppliers including the timely submission of

satisfactory invoices.

Employees

Applications for employment by disabled persons are always fully considered, bearing in mind the respective

aptitudes and abilities of the applicant concerned. In the event of members of staff becoming disabled, every effort

is made to ensure that their employment with the Group continues and that appropriate training is arranged. It is

the policy of the Group that the training, career development and promotion of a disabled person should, as far as

possible, be identical to that of a person who does not suffer from a disability. The Group places considerable

value on the involvement of its employees and has continued to keep them informed on matters affecting them as

employees and on the various factors affecting the performance of the Group and the Company. This is achieved

through formal and informal meetings and the Group website.

Auditor

The auditors, Deloitte LLP, have expressed their willingness to continue in office as auditor and appropriate

arrangements have been put in place for them to be deemed reappointed as auditor pursuant to sections 485 – 488

of the Companies Act 2006.

Approved by the Board and signed on its behalf by:

I T Lowitt

Director

29 March 2017

afayyaz
Stamp
Page 9: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

8

DIRECTORS’ RESPONSIBILITIES STATEMENT

The directors are responsible for preparing the Annual Report and Financial Statements in accordance with

applicable law and regulations. Company law requires the directors to prepare financial statements for each

financial year. Under that law the directors have elected to prepare the financial statements in accordance with

International Financial Reporting Standards (‘IFRSs’) as adopted by the European Union. In accordance with

company law, the directors must not approve the financial statements unless they are satisfied that they give a true

and fair view of the state of affairs of the Group and Company and of the profit or loss of the Group and Company

for that period.

In preparing these financial statements, International Accounting Standard (‘IAS’) 1 requires directors to:

▪ properly select and apply accounting policies;

▪ present information, including accounting policies, in a manner that provides relevant, reliable,

comparable and understandable information;

▪ provide additional disclosures when compliance with the specific requirements in IFRSs are

insufficient to enable users to understand the impact of particular transactions, other events and

conditions on the Group and Company’s financial position and financial performance; and

▪ make an assessment of the Group and Company’s ability to continue as a going concern.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the

Group and Company’s transactions and disclose with reasonable accuracy at any time the financial position of the

Group and Company and enable them to ensure that the financial statements comply with the Companies Act 2006.

They are also responsible for safeguarding the assets of the Group and Company and, hence, for taking reasonable

steps for the prevention and detection of fraud and other irregularities.

The directors are responsible for the maintenance and integrity of the corporate and financial information included

on the Company’s website. Legislation in the United Kingdom governing the preparation and dissemination of

financial statements may differ from legislation in other jurisdictions.

Page 10: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

9

STRATEGIC REPORT

Review of financial performance

2016 was a record year for the firm with highest Operating Profit and Profit Before Tax (‘PBT’). The positive

earnings trajectory over the past four years is apparent in almost all the metrics, but particularly PBT (excluding

one-time revenues) which excludes gains on Eclipse sale in 2014 and sale of LCH shares in 2013. PBT (excluding

one-time revenues) was $27 million in 2016, almost $10 million more than 2015 and $35.5 million above 2013:

2016

$ million

2015

$ million

2014

$ million

2013

$ million

2016

v 2015

$ million

Revenue 330.4 347.7 368.8 358.1 (17.3)

Expenses (304.1) (325.0) (353.7) (367.2) 20.9

Operating profit / (loss) 26.3 22.7 15.1 (9.1) 3.6

Net Financing (0.2) (1.2) (0.5) 0.6 1.0

Profit / (loss) before tax /

(before one-time

expenses)

26.1

21.5

14.6

(8.5)

4.6

One-time expenses 0.9 (3.9) (1.3) - 4.8

Profit / (loss) before tax /

(before one-time

revenues)

27.0

17.6

13.3

(8.5)

9.4

One-time revenues - - 9.3 2.3 -

Profit / (loss) before tax 27.0 17.6 22.6 (6.2) 9.4

In addition to the Statutory Account numbers, management also focuses on key performance indicators (‘KPIs’)

including Adjusted PBT and Adjusted Earnings Before Income Tax Depreciation and Amortisation (‘Adjusted

EBITDA’) which reflect the underlying profitability of the business by excluding specific one-time items and

impact of investments and cost to exit businesses. In 2016, Adjusted PBT was $32.4 million, $10 million above

2015 and $38 million above 2013. In 2016, management was able to renegotiate the dilapidation expenses in

relation to the exit of Copthall Avenue and Grosvenor Place premises reversing the prior year provisions; the

Group also incurred run-off costs following the closure of Securities and Easyscreen ($1.8 million) and investment

in new initiatives ($2.8 million) which, despite lowering current year earnings, form the platform for future growth.

Page 11: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

10

Review of financial performance (continued)

2016

$ million

2015

$ million

2014

$ million

2013

$ million

2016

v 2015

$ million

Profit / (loss) before

tax (reported) 27.0 17.6 22.6 (6.2) 9.4

Exclude:

One-time revenue - - 9.3 - -

One-time expenses 0.9 (3.9) (1.3) (0.5) 4.8

Renegotiated

dilapidations (0.9) - - - (0.9)

Exiting Securities

and Easyscreen (1.8) - - - (1.8)

Investments in new

initiatives (2.8) - - - (2.8)

Owner fees (0.8) (0.7) (1.5) (0.5) (0.1)

Adjusted profit / (loss)

before tax

32.4

22.2

16.1

(5.2)

10.2

Similarly, Adjusted EBITDA was a record $37.1 million, up $6 million on 2015 and $26 million on 2013:

2016

$ million

2015

$ million

2014

$ million

2013

$ million

2016

v 2015

$ million

Adjusted profit / (loss)

before tax 32.4 22.2 16.1 (5.2) 10.2

Exclude:

Depreciation &

amortisation (2.9) (4.7) (6.5) (9.3) 1.8

Financing costs (1.8) (1.8) (0.9) - -

Other non-operating costs - (2.3) (1.3) (7.2) 2.3

Adjusted EBITDA 37.1 31.0 24.8 11.3 6.1

Page 12: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

11

Review of financial performance (continued)

Typically for a commodity broker, increasing commodity prices and high volatility have a positive impact on

performance. Over the past four years, as earnings have been improving, markets have not been helpful. Over the

period 2010-15 the Bloomberg Commodity Index declined 51%. The index improved by 11% in 2016, and while it

is premature to ‘call the bottom’, improving prices would help our clients and our business.

Bloomberg Commodity Index (BCOM)

Year-end points:

Similarly, volatility over the past four years has been below the long term average. In 2016, despite spikes

following the UK’s referendum on EU membership (‘BREXIT’) and the US election, average volatility level for

the year was 5% lower than 2015 (but above the level of 2013-14):

VIX Index

Average for the year:

89

110

135 146

171 167

185

117

139

162

141 139 126

104

79 88

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

Bloomberg Commodity

Index (BCOM)

Yead-end points -51%

+11%

25.7 27.3

22.0

15.5 12.8 12.8

17.5

32.7 31.5

22.5 24.2

17.8

14.2 14.2 16.7 15.8

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

VIX Index

Average for year

Page 13: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

12

Review of financial performance (continued)

Business review

The Group is organised into four business segments across three geographic regions. Management evaluates the

Group’s performance on a Net Revenue basis – i.e. Gross Revenue (see note 5 to the Financial Statements) less

Cost of Trade. On this basis, and excluding closed businesses, the Group generated Net Revenue of $242 million,

$1.7 million below 2015; on an FX neutral basis, excluding the impact of lower GBP / USD rate, Net Revenue was

$3 million above 2015:

31 December 2016

Europe

$ million

North

America

$ million

Asia

$ million

Total

$ million

Commodities 147.0 39.0 16.2 202.2

Futures and Securities 13.5 6.2 - 19.7

Market Access 15.8 - - 15.8

Other 3.7 0.6 - 4.3

180.0 45.8 16.2 242.0

Closed businesses* 1.1 - - 1.1

Revenue 181.1 45.8 16.2 243.1

31 December 2015

Europe

$ million

North

America

$ million

Asia

$ million

Total

$ million

Commodities 152.3 36.7 13.8 202.8

Futures and Securities 15.7 5.0 - 20.7

Market Access 18.8 - - 18.8

Other 0.8 0.7 - 1.5

187.6 42.4 13.8 243.8

Closed businesses* 7.2 - - 7.2

Revenue 194.8 42.4 13.8 251.0

*Closed businesses include Securities and Easyscreen.

Page 14: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

1 Market share is calculated as Marex volumes as a percentage of externally sourced total market volume information

13 2 External source: Combination of Intercontinental Exchange (‘ICE’) and Chicago Mercantile Exchange (‘CME’)

3 External source: The London Energy Brokers Association (‘LEBA’)

4 External source: CME

Review of financial performance (continued)

Business review (continued)

Commodities

31 December 2016

Europe

$ million

North

America

$ million

Asia

$ million

Total

$ million

Commodities

Energy 78.7 31.0 5.7 115.4

Metals 40.9 4.8 10.6 56.3

Agriculture 27.4 3.2 - 30.6

Commodities revenue 147.0 39.0 16.3 202.3

31 December 2015

Europe

$ million

North

America

$ million

Asia

$ million

Total

$ million

Commodities

Energy 83.1 29.3 5.2 117.6

Metals 42.0 4.3 8.6 54.9

Agriculture 27.2 3.1 - 30.3

Commodities revenue 152.3 36.7 13.8 202.8

Energy

Energy Net Revenues were $2.1 million down on 2015 (-1.7%), with growth in North America and Asia offset by a

decline in Europe. The reduction in European markets was primarily due to lower GBP / USD rate.

The business leading market share was maintained and the firm continued to be top three in the following key

products.

Product Market Share1 Rank

European Fuel Oil 31%2 Number 1

Natural Gas (NBP) 29%3 Top 3

UK & European Power 17%3 Top 3

New York Ethanol 46%3 Number 1

Chicago Ethanol 20%4 Top 3

The majority of the investments undertaken by the Group in 2016 were in Energy, and largely in North America.

The OTC Energy market in North America is estimated to be as large as European markets, and our long-term aim

is to have a North American business of similar size to Europe: the initiatives in Canadian Physical Crude, Houston

Light Ends and US Power are key steps towards this goal. There have also been investments in Europe and Asia,

mainly in Financial Gasoline, Freight and Light Ends.

Page 15: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

5 Market share is calculated as Marex volumes as a percentage of externally sourced total market volume information

146 External source: ICE

7 External source: Euronext

Review of financial performance (continued)

Business review (continued)

Commodities (continued)

Metals

Metals Net Revenues were $1.3 million above 2015 (+2.4%), despite the decline in LME volumes (down 8%)

which indicates our growing market share and competitiveness.

The Group has maintained its market leader position on the LME with a share of 20% of total volumes and 22% of

LME electronic platform (LME Select).

As banks continue to withdraw from the Metals market, or limit their involvement, we see opportunities to provide

services to institutional clients and have evolved our offering to serve this segment.

Agriculturals

Business Net Revenues were flat, with record level broking commission offset by lower market making. The

Group is a market leader in options markets:

Product Market Share5 Rank

London/NY Cocoa Options 36%6 Top 2

London/NY Coffee Options 22%6 Top 2

London/NY Sugar Options 11%6 Top 3

European Grains 24%7 Top 2

Futures and Securities, and Market Access

FF&O

Net Revenues for 2016 were $15.9 million, in line with last year, with increased contribution from North American

desks offsetting a reduction in Europe. Market conditions improved in the second part of the year. In 2016, the

Group restructured a few underperforming desks and hired a high quality team in anticipation of an improving

macro environment for this business.

ProTrader

2016 was a challenging year for ProTrader as it was for the entire industry. These markets were impacted by a

flattening yield curve and central bank forward guidance limiting short term trading opportunities and the

continued uncertainty around MiFID II.

Page 16: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

15

Review of financial performance (continued)

Balance sheet

Shareholders’ equity grew by $0.2 million following the net effect of profit after tax of $20.5 million (2015: $17.6

million), dividend payments made to shareholders of $20.0 million (2015: $nil) and the reduction in value of

available-for-sale assets (net of deferred tax) of $0.3 million (2015: $1.3 million). Since 2011, tangible equity has

increased by $47.9 million (26%). Since 2013, this has added $39.7 million (20.5%) to tangible equity compared

to $8.3 million (4.5%) from 2011 to 2013.

2016

$ million

2015

$ million

2014

$ million

2013

$ million

2012

$ million

2011

$ million

Shareholders’ equity 373.8 373.6 357.3 338.8 345.4 331.6

Goodwill (141.0) (141.0) (144.0) (145.6) (145.6) (146.7)

Tangible equity 232.8 232.6 213.3 193.2 199.8 184.9

2016 2015

$ million Assets Liabilities Assets Liabilities

Cash and cash equivalents 188.2 - 158.3 -

Financial instruments – held to maturity

(Treasuries) 120.2 - 119.5 -

Warrant inventory - - 15.9 -

Repurchase agreements - - - (18.9)

Short term borrowings - (40.0) - -

Liquid resources 308.4 (40.0) 293.7 (18.9)

Trade receivables 622.9 - 634.9 -

Other receivables 23.4 - 13.5 -

Trade payables - (647.3) - (632.8)

Other payables - (60.3) - (74.0)

Trade and other receivables / (payables) 646.3 (707.6) 648.4 (706.8)

Financial instruments 24.0 (12.0) 4.9 (3.5)

Matched principal broking (FX and bullion) 24.0 (12.0) 4.9 (3.5)

Net tax liabilities - (1.3) - (2.4)

Provisions - (0.3) - (1.4)

Non-current assets 15.3 - 18.6 -

Other 15.3 (1.6) 18.6 (3.8)

994.0 (761.2) 965.6 (733.0)

Tangible equity 232.8 232.6

Page 17: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

16

Review of financial performance (continued)

Balance sheet (continued)

Overall, total assets on the balance sheet have increased by $28.3 million (3%) year-on-year. Trade payables,

representing client activity grew $14.5 million (2%) from $632.8 million to $647.3 million as at 31 December

2016. Trade receivables, mainly driven by margin requirements with exchanges reduced as the Group posted $12.0

million (1%) less collateral from $634.9 million to $622.9 million at the year end.

Deployment of equity

The Group’s liquid resources have decreased by $6.4 million (2%) from $274.8 million to $268.4 million as at 31

December 2016. Cash and cash equivalents have increased by $29.9 million (19%) year-on-year with the Group

utilising $35.0 million (2015: $nil) of the available credit facility and $5 million (2015: $nil) of bank overdraft

facilities at the year end. While the total US Treasuries are flat year-on-year the Group had no repurchase

agreements as at 31 December 2016 (2015: $18.9 million). The Group purchased $15.9 million of warrant

inventory as at 31 December 2015 which was delivered in the first week of 2016. Net financial instruments have

increased by $10.6 million with other net payables down $21.1 million (46%) year-on-year.

2016

$ million

2015

$ million

2014

$ million

2016 v 2015

$ million

2016 v 2015

%

Cash and cash equivalents 188.2 158.3 159.1 29.9 19%

Financial instruments –

held to maturity

(Treasuries) 120.2 119.5 120.0 0.7 -

Warrant inventory - 15.9 - (15.9) (100%)

Repurchase agreements - (18.9) - 18.9 (100%)

Short term borrowings (40.0) - (25.0) (40.0) -

Liquid resources 268.4 274.8 254.1 (6.4) (2%)

Trade receivables 622.9 634.9 542.7 (12.0) (2%)

Trade payables (647.3) (632.8) (698.2) (14.5) 2%

Net trade (payables) /

receivables

(24.4)

2.1

(155.5)

(26.5)

(1,262%)

Financial instruments –

assets 24.0 4.9 12.2 19.1 390%

Financial instruments –

liabilities (12.0) (3.5) (10.3) (8.5) (243%)

Matched principal

broking / (FX and

bullion)

12.0

1.4

1.9

10.6

757%

Other receivables 23.4 13.5 15.7 9.9 73%

Other payables (60.3) (74.0) (66.4) 13.7 (19%)

Net tax liabilities (1.3) (2.4) (6.6) 1.1 (46%)

Provisions (0.3) (1.4) (1.2) 1.1 (79%)

Non-current assets 15.3 18.6 20.0 (3.3) (18%)

Other net payables (23.2) (45.7) (38.5) 22.5 (49%)

Tangible equity 232.8 232.6 62.0 0.2 -

Page 18: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

17

Review of financial performance (continued)

Balance sheet (continued)

Liquidity

In addition to cash and unencumbered US Treasuries, the firm includes warrants in its liquid resources as the Group

is able to convert these to cash on a trade date plus one-day basis. In addition, forward profits on LME, included in

trade receivables, are also a source of liquidity. These arise from closed-out house positions that are in the money,

but the cash is not received until the position finally settles. The firm is able to utilise these profits as part of its

collateral requirements at the LME or, if in excess to requirements, they can be sold or factored.

Group Liquidity Resource is a measure of the extent to which the Group has cash or assets that can be quickly

converted to meet immediate and short-term obligations. Group liquidity resources consist of non-segregated cash,

unencumbered US Treasuries, House LME warrant inventory, and House LME forward profits in excess of margin

requirements. Group Liquidity Resources were $218 million at 31 December 2016 (2015: $241 million). Average

Liquidity Resources in 2016 were $202 million (2015: $213 million). Considering just Cash and Unencumbered

US Treasuries, the 2016 average was $191 million (2015: $191 million); holding liquidity in the form of warrants

on forward profits is, as evidenced by the difference, relatively modest. The increase in average Liquidity

Resources was driven by continued profitability of the Group; somewhat lower Exchange Default Fund

requirements (2016: average of $42 million; 2015: average of $38 million); and, most importantly, higher LME

aggregation benefit (quantity of longs and shorts within the LME portfolio).

Regulatory capital

The Group has maintained its strong capital base throughout the year as well as at the balance sheet date.

As at 31 December 2016, the Group had a total minimum capital requirement (‘Pillar 1’) of $87.6 million (2015:

$70.4 million) and capital resources of $211.9 million (2015: $211.7 million) equating to an excess of $124.3

million (2015: $141.3 million), total capital ratio of 19.34% (2015: 24.04%) and a solvency ratio of 242% (2015:

301%).

The average capital requirement for the year was $91.5 million (2015: $92.0 million), supported by $211.7 million

(2015: $209.5million) of regulatory capital resources and, therefore, the average surplus was $120.2 million (2015:

$117.5 million).

Return on assets

The return on assets, as required by Article 90 of the Capital Requirements Directive, as at 31 December 2016 is

7% (2015: 6%). The return on assets reflects the Company’s operating profit of $26.3 million (2015: $22.7

million) as a percentage of the net assets $373.8 million (2015: $373.6 million).

Page 19: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

18

Overview of risk management

Excellence in risk management is at the core of Marex Spectron’s business operations. The Group has stringent

risk management procedures and well-established risk management processes. Marex Spectron views risk

management as a key factor in delivering its strategic business aims and objectives whilst ensuring its long-term

sustainability and effective corporate governance.

Business strategy, risk strategy and risk appetite are all aligned to ensure that decision making across the Group

reflects the correct approach to risk. By taking into account the risks posed across each of the business lines, the

effective management of capital and liquidity within Marex Spectron is optimised. The Marex Spectron Enterprise

Wide Risk Management (‘EWRM’) framework sets out the risk management approach and consists of the

following eight key components:

Page 20: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

19

Overview of risk management (continued)

Governance structure

Marex Spectron’s risk governance model underpins how the risk management structure is directed across the

Group.

In pursuit of effective risk governance, a ‘Three Lines of Defence’ model has been adopted in conjunction with a

strong risk culture, good communication and understanding and a strong sense of risk awareness across the Group:

▪ the first line of defence covers the controls in place to deal with and manage the day-to-day risk

management within the business units, support functions and embedded operational risk staff;

▪ the second line of defence consists of the specialist control functions which make up the risk

management infrastructure of the Group; and

▪ the third line of defence is Marex Spectron’s internal audit function auditing and covering all aspects of

both the first and second lines of defence.

Page 21: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

20

Overview of risk management (continued)

Risk control and reporting framework

There is a clearly defined suite of risk tools, processes, policies and procedures in place that allow for the

successful monitoring and control of the risks of the Group and a clearly defined escalation and reporting process to

senior management and other key staff within the Group. The control framework consists of the following

components:

Risk policy framework

Marex Spectron’s policy framework sets out the rules and guidelines for drafting, approving, communicating,

implementing, embedding and monitoring compliance for all risk related policies across the Group. The policy

framework defines the key policies necessary to manage all risks arising within each risk category across the Group

and aims to deliver a focused and consistent enterprise wide view of risk. Specific policies and procedures have

been implemented to address each of the principal risks, see below. The process and methodology for addressing

each risk may differ depending on the relevant business unit.

The policy framework sets the minimum standards for how each risk is:

▪ identified – the method used to identify risk exposures;

▪ measured – how the likelihood, severity and impact / quantum of those risks is measured;

▪ managed – how minimum standards are set to manage the risks;

▪ controlled – the controls in place to help mitigate the risks;

▪ reported – how the risks are communicated, reported, and escalated; and

▪ assured – how the risk management process is overseen by an independent function

Page 22: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

21

Overview of risk management (continued)

Internal audit

Marex Spectron has an internal audit function and this represents the Group’s third line of defence providing

independent assurance to senior management and the Board. The objectives of Internal Audit are to assess the

effectiveness of the Group’s risk management, internal controls and governance process; whether operational and

financial controls are appropriate and consistently applied; the effectiveness of internal controls for the

safeguarding of assets; the reliability and integrity of management information; and the adequacy of processes to

ensure compliance with applicable laws and regulations.

The Board’s assessment of the principal risks

The directors of the Group confirm that they have carried out a robust assessment of the principal risks facing the

Group, including those that would threaten its business model, future performance, solvency or liquidity.

The Group faces a variety of risks that are inherent in its normal course of business. These risks can be categorised

into: Financial; Operational; and Strategic and Business. The following are deemed to be the principal risks and

uncertainties that could affect Marex Spectron’s activities within each of these areas and are described, below,

along with how the Group seeks to manage or mitigate each of these risk exposures.

Financial risk

Liquidity risk

Liquidity is essential to Marex Spectron’s businesses. Liquidity risk is the risk that the Group either does not have

sufficient financial resources available to meet its obligations as they fall due or can only secure such resources at

excessive cost.

Liquidity risk is assessed and managed under the Individual Liquidity Adequacy Assessment (‘ILAA’) and

liquidity risk framework. The Group’s liquidity could be impaired by an inability to sell assets or unforeseen

outflows of cash or collateral. This situation may arise due to circumstances beyond Marex’s control. This

includes general market disruption, operational problems that affect third parties or the Group or from the

perception amongst market participants that the Group is experiencing greater liquidity risk.

Marex Spectron’s ability to sell assets may be further impaired if other market participants are seeking to sell

similar assets at the same time as is likely to occur in a liquidity or other market crisis. Given the Group’s

significant position on a number of exchanges and its market-maker role, there is an expectation that Marex

Spectron will continue to make a market in stress conditions.

To mitigate liquidity risk, the Group has implemented robust cash management policies and procedures that

monitor liquidity daily to ensure that Marex Spectron has sufficient resources to meet its margin requirements at

clearing houses and third party brokers. There are strict guidelines in relation to the products and product duration

into which excess liquidity can be invested.

Excess liquidity is invested in highly liquid instruments, such as cash deposits with financial institutions for a

period of less than three months and US Treasuries with a maturity of up to two years.

The financial liabilities are based upon rates set on a daily basis, (apart from Marex’s financing of warrants and the

credit facility, where the rates are set for the term of the loan and / or repo). For assets not marked-to-market, there

are no material differences between their carrying and fair value.

Marex Spectron has a varied client base that can hold both long and short positions in the same product. As a

significant market maker, the Group’s exchange exposure has, at any given point in time, some element of liquidity

offset or aggregation benefit.

In the event of a liquidity issue arising, the Group has recourse to existing global cash resources. Marex Spectron

also has a $15 million uncommitted overdraft facility and a $65 million committed revolving credit facility as

additional contingency funding.

Page 23: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

22

Overview of risk management (continued)

Financial risk (continued)

Credit risk

Credit risk is the risk that third parties who owe Marex Spectron money, securities or other assets fail to perform on

their contractual obligations. This situation may arise due to their lack of liquidity, bankruptcy, operational failure

as well as for other reasons. In addition, failure or concerns regarding a default by an institution could lead to

significant liquidity problems, losses or subsequent defaults of other institutions. This could adversely affect the

Group, given the commercial soundness of many financial institutions may be closely related as a result of clearing,

credit, trading or other relationships between institutions.

Marex Spectron is exposed to credit risk arising from a number of sources, including:

▪ the temporary credit exposure that arises from the timing of margin payments, where the Group

delivers margin to a clearing house before receiving the matching payment either from a non-credit

client or from a credit client from whom margin has been called since the credit limit has been

exceeded;

▪ the extension of credit to clients in relation to initial and variation margin payments;

▪ settlement risk arising from the release of currency or warrants prior to settlement by the counterparty –

given that most settlement is on a delivery-versus-payment basis, this is mainly confined to a small

number of trades in LME warrants with the most creditworthy counterparties; and

▪ exposure to non-client counterparties, including exchanges, clearing houses or deposit-taking

institutions holding assets of the Group, including exchange memberships, default fund contributions

and cash deposits.

This risk is mitigated by the robust client approval process, the taking of collateral and the continual and real time

monitoring of clients / counterparties and their exposures. Most clients are required to pre-fund their obligations to

Marex, but a subset are granted credit facilities following detailed qualitative and quantitative analysis and approval

by the Group’s Credit Committee and, if necessary, the Board Risk Committee. Concentrations of risk are

carefully monitored and controlled, whether they are the result of a single client or counterparty, geography, sector,

market or product and remedial action is taken where either a risk appetite level is approached / breached or where

considered necessary for other reasons.

Market risk

Market risk is defined as the risk of loss that arises from fluctuations in the values of the Group’s traded positions

due to adverse changes in market prices, volatilities, interest rates and foreign exchange. It also includes the risks

that arise from open foreign exchange and interest rate positions on the Statement of Financial Position; for

example, via our cash and investment balances and bank borrowings.

Marex Spectron incurs market risk primarily as a result of taking positions in the course of its market-making

business. The Group generally aims to match buyers and sellers in the markets where it operates: the Group has a

relatively low appetite for intraday position risk, but in businesses such as Metals and Agricultural Commodities it

is necessary to augment market liquidity with firm liquidity.

Market risk can also arise in relation to client-driven trading where timing issues or market opening hours result in

the business carrying a position for a short period of time, typically overnight. Spread, outright and option risks

result from cash and derivative exposures in commodities, foreign exchange and financial products. Risks are

generally limited to highly liquid exchange-traded and foreign exchange contracts.

The Board has clearly defined its risk appetite for market risk and a variety of measurement methodologies,

including Value-at-Risk (‘VaR’), scenario analysis and stress testing are used to quantify and assess the levels of

market risk to which the Group is exposed. Positions can be managed or additional hedging instruments can be

acquired to ensure risk remains within the defined risk appetite.

Page 24: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

23

Overview of risk management (continued)

Financial risk (continued)

Market risk (continued)

Marex’s overall exposure to market risk is mitigated by its operation as an intermediary on most transactions. As

an intermediary, the Group aims to minimise its market risk by matching buyers and sellers. However, from time-

to-time, Marex will take the risk of a given trade onto its own books within pre-defined parameters and risk limits

which are monitored and controlled by the Risk Department.

Capital management

The primary objective of Marex Spectron’s capital management is to ensure that it maintains strong capital ratios in

order to support its business growth as well as to maximise shareholder value. The Group manages its capital

structure and makes adjustments to it in light of changes in economic conditions. In addition, Marex manages its

capital so that it complies with the requirements of the regulatory authorities, as well as ensuring its capital base is

adequate to cover the risks inherent in the business as defined in the Group’s Internal Capital Adequacy

Assessment Process (‘ICAAP’) document.

Operational risk

Operational risk is the risk of losses resulting from inadequate or failed internal processes, people, and systems or

from external events. It is inherent in all the products, activities, processes and systems. Therefore, managing

operational risk is considered the responsibility of all Group employees.

The Board recognises the business imperative to identify, assess, manage, mitigate and report operational risk. The

firm adopts a ‘Three Lines of Defence’ model, where each line of defence has specific roles and responsibilities in

the implementation of the Operational Risk Framework (‘ORF’). The Risk Function has the responsibility to

design, maintain and implement the ORF.

The Framework enables the directors to define the operational risk profile of the firm via the performance of

periodic risk assessments, the collection of loss data through internal risk event reporting systems and the

monitoring of the set of key risk indicators, ensuring the risk profile stays within the firm’s risk appetite.

All the framework’s components concur with the definition of the scenario analysis used in determining the

Group’s internal capital assessment for operational risk within its ICAAP.

Information security / cyber risk

Information security, data confidentiality, integrity and availability of information are of critical importance to our

businesses. Technology risk is inherent not only in the Group’s information technology assets, but also in the

people and processes that interact with them. Cyber risk, which is part of technology risk, is the risk that Marex

Spectron’s systems will not operate properly or will be compromised as a result of cyber-attacks, security breaches,

unauthorized access, loss, destruction or alteration of data, unavailability of service, computer viruses or other

events that could have an adverse security impact. As a result, the Group could be subject to litigation, suffer

financial loss not covered by insurance, experience disruption of businesses, liability to clients, regulatory

intervention or reputational damage.

Although Marex Spectron has business continuity plans, businesses face a wide variety of operational risks,

including technology risk arising from dependencies on information technology, third-party suppliers and the

worldwide telecommunications infrastructure. The increasing sophistication of cyber-attacks, means that a cyber-

attack is inherently unpredictable and could occur without detection for an extended period of time.

The Group maintains active links with peer associations and appropriate government agencies to keep abreast of

developments and has timely access to cyber threat intelligence. Service and infrastructure disruption risks are

managed through Marex’s business continuity management plan, the incident response plan, the operational risk

management program and other contingency and resiliency plans.

Page 25: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

STRATEGIC REPORT (CONTINUED)

24

Overview of risk management (continued)

Operational risk (continued)

Legal and compliance (continued)

Compliance or regulatory risk arises from a failure or inability to comply with the laws, regulations or codes

applicable specifically to the financial services industry. Non-compliance can lead to fines, public reprimands,

enforced suspensions of services or, in extreme cases, withdrawal of authorisation to operate.

Companies within the Group are subject to authorisation by the LME, the CME, ICE, the NYSE Euronext and

Eurex. Marex Spectron is regulated on a consolidated basis in the UK by the FCA, in the US by the NFA and

CFTC, in Hong Kong by the SFC, and in Singapore by the MAS and IES.

Legal risk can also arise through litigation or the failure of contractual documentation when relied upon. Litigation

risk is difficult to completely eliminate, but the Group mitigates this risk through its transparent and considered

approach to the activities which it undertakes. The failure of contractual documentation when relied upon is

mitigated by using market standard documents wherever possible and ensuring that bespoke or amended

documentation is thoroughly reviewed by the internal Legal Department and / or external counsel.

Strategic and business risk

This risk is defined as the impact of a change or a failure to change Marex Spectron’s business model which

impacts its ability to meet its strategic or financial objectives. It might arise from the pursuit of an unsuccessful

business plan, from making slow or poor business decisions, from the substandard execution of decisions, from

inadequate resource allocation, or from a failure to respond well to changes in the business environment.

The Group’s Board and Executive Committee regularly review Marex Spectron’s regulatory and business

environment, the performance and capital requirements of its business lines, the level of investment in new and

existing activities and its remuneration policy. The Group performs on-going surveillance of market trends, the

regulatory landscape and customer demand. This is supported by risk scenario contingency planning and the

assessment of emerging risks.

The directors, in preparing this strategic report, have complied with s414C of the Companies Act 2006.

I T Lowitt

Director

29 March 2017

afayyaz
Stamp
Page 26: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

25

INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF

MAREX SPECTRON GROUP LIMITED

We have audited the financial statements for Marex Spectron Group Limited for the year ended 31 December 2016

which comprise the consolidated income statement, the consolidated statement of other comprehensive income, the

statements of financial position, the statements of changes in equity, the cash flow statements and the related notes

1 to 35. The financial reporting framework that has been applied in their preparation is applicable law and

International Financial Reporting Standards (‘IFRSs’) as adopted by the European Union and, as regards the parent

company financial statements, as applied in accordance with the provisions of the Companies Act 2006.

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the

Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those

matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent

permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company’s

members as a body, for our audit work, for this report, or for the opinions we have formed.

Respective responsibilities of directors and auditor

As explained more fully in the Directors’ Responsibilities Statement, the directors are responsible for the

preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility

is to audit and express an opinion on the financial statements in accordance with applicable law and International

Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices

Board’s Ethical Standards for Auditors.

Scope of the audit of the financial statements

An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to

give reasonable assurance that the financial statements are free from material misstatement, whether caused by

fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the Group’s and

the parent Company’s circumstances and have been consistently applied and adequately disclosed; the

reasonableness of significant accounting estimates made by the directors; and the overall presentation of the

financial statements. In addition, we read all the financial and non-financial information in the annual report to

identify material inconsistencies with the audited financial statements and to identify any information that is

apparently materially incorrect based on, or materially inconsistent with, the knowledge acquired by us in the

course of performing the audit. If we become aware of any apparent material misstatements or inconsistencies we

consider the implications for our report.

Opinion on financial statements

In our opinion:

▪ the financial statements give a true and fair view of the state of the Group’s and of the parent

company’s affairs as at 31 December 2016 and of the Group’s profit for the year then ended;

▪ the Group financial statements have been properly prepared in accordance with IFRSs as adopted by

the European Union;

▪ the parent company financial statements have been properly prepared in accordance with IFRSs as

adopted by the European Union and as applied in accordance with the provisions of the Companies Act

2006; and

▪ the financial statements have been prepared in accordance with the requirements of the Companies Act

2006.

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

▪ the information given in the Strategic Report and the Directors’ Report for the financial year for which

the financial statements are prepared is consistent with the financial statements; and

▪ the Strategic Report and the Directors’ Report have been prepared in accordance with applicable legal

requirements.

In the light of the knowledge and understanding of the company and its environment obtained in the course of the

audit, we have not identified any material misstatements in the Strategic Report and the Directors’ Report.

Page 27: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF

MAREX SPECTRON GROUP LIMITED (CONTINUED)

26

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report

to you if, in our opinion:

▪ adequate accounting records have not been kept by the parent company, or returns adequate for our

audit have not been received from branches not visited by us; or

▪ the parent company financial statements are not in agreement with the accounting records and returns;

or

▪ certain disclosures of directors' remuneration specified by law are not made; or

▪ we have not received all the information and explanations we require for our audit.

James Polson (Senior Statutory Auditor)

For and on behalf of Deloitte LLP

Chartered Accountants and Statutory Auditors

London, United Kingdom

29 March 2017

Page 28: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

27

CONSOLIDATED INCOME STATEMENT

FOR THE YEAR ENDED 31 DECEMBER 2016

Notes

2016

$’000

2015

$’000

Revenue 5 330,370 347,747

Operating expenses (304,044) (325,021)

Operating profit 6 26,326 22,726

Other income 9 26 95

Other expense 9 876 (3,900)

Finance income 10 1,836 554

Finance expense 10 (2,057) (1,856)

Profit before taxation 11(b) 27,007 17,619

Tax 11(a) (6,515) 25

Profit after taxation 20,492 17,644

CONSOLIDATED STATEMENT OF OTHER COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31 DECEMBER 2016

Notes

2016

$’000

2015

$’000

Profit after taxation 20,492 17,644

Other comprehensive income

Items that may be reclassified subsequently to profit or

loss when specific conditions are met

Loss on revaluation of investments – available-for-sale

(‘AFS’) 16(a) (365) (1,729)

Deferred tax on revaluation of investments – AFS 11(c), 25 104 379

Other comprehensive loss, net of tax (261) (1,350)

Total comprehensive income 20,231 16,294

All operations are continuing for the current and prior years.

The notes on pages 33 to 85 form part of these financial statements.

Page 29: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

28

STATEMENTS OF FINANCIAL POSITION

AS AT 31 DECEMBER 2016

Group Company

Notes

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Assets

Non-current assets

Goodwill 13 140,969 140,969 - -

Other intangible assets 14 537 771 46 -

Property, plant and equipment 15 2,501 3,779 - -

Investments – AFS 16(a) 6,896 7,261 3,134 3,165

Investments in subsidiaries 16(b) - - 331,722 331,722

Deferred tax 25 4,759 5,290 120 111

Other assets 18 - 908 - -

Subordinated loans due to group

undertakings 19 - - 17,500 9,000

Financial instruments – fair value

through profit or loss, pledged as

collateral 20 653 658 - -

Financial instruments – held to

maturity 21 12,500 40,936 - -

Financial instruments – held to

maturity, pledged as collateral 21 22,486 44,093 - -

Total non-current assets 191,301 244,665 352,522 343,998

Current assets

Inventory 17 - 15,870 - -

Derivative instruments 24 24,012 4,936 - -

Financial instruments – held to

maturity 21 23,564 9,999 - -

Financial instruments – held to

maturity, pledged as collateral 21 61,659 24,496 - -

Trade and other receivables 22 646,301 648,399 57 27,015

Corporation tax 322 1,095 - -

Cash and cash equivalents 188,178 158,261 486 116

Total current assets 944,036 863,056 543 27,131

Total assets 1,135,337 1,107,721 353,065 371,129

The notes on pages 33 to 85 form part of these financial statements.

Page 30: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

29

STATEMENTS OF FINANCIAL POSITION

AS AT 31 DECEMBER 2016 (CONTINUED)

Group Company

Notes

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Liabilities

Current liabilities

Derivative instruments 24 12,027 3,542 - -

Trade and other payables 26 707,580 706,750 1,877 839

Repurchase agreements - 18,938 - -

Short-term borrowings 23 40,000 - - -

Corporation tax 1,632 3,491 - 74

Provisions 27 265 1,413 - -

Total current liabilities 761,504 734,134 1,877 913

Total liabilities 761,504 734,134 1,877 913

Total net assets 373,833 373,587 351,188 370,216

Equity

Share capital 28 176,238 176,238 176,238 176,238

Share premium 29 134,301 134,286 134,286 134,286

Retained earnings 29 64,627 64,135 41,178 60,185

Revaluation reserve 29 (1,089) (828) (514) (493)

Other reserves 29 (244) (244) - -

Total equity 373,833 373,587 351,188 370,216

The Company reported a profit for year ended 31 December 2016 of $992,938 (2015: $48,495,000).

The financial statements on pages 27 to 85 were approved and authorised for issue by the Board of Directors on

21 March 2017 and signed on its behalf by:

I T Lowitt

Director

29 March 2017

Registration Number: 05613060

The notes on pages 33 to 85 form part of these financial statements.

afayyaz
Stamp
Page 31: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

30

STATEMENT OF THE CHANGES IN EQUITY AND MOVEMENTS IN RESERVES

FOR THE YEAR ENDED 31 DECEMBER 2016

Group

Share

capital

$’000

Share

premium

$’000

Retained

earnings

$’000

Reval-

uation

reserve

$’000

Other

reserve

$’000

Total

$’000

At 1 January 2015 176,238 134,286 46,491 522 (244) 357,293

Profit for the period - - 17,644 - - 17,644

Loss on revaluation of

investments – AFS - - - (1,729) - (1,729)

Deferred tax on revaluation of

investments – AFS - - - 379 - 379

At 31 December 2015

and 1 January 2016

176,238

134,286

64,135

(828)

(244)

373,587

Profit for the period - - 20,492 - - 20,492

Loss on revaluation of

investments – AFS - - - (365) - (365)

Deferred tax on revaluation of

investments – AFS - - - 104 - 104

Capital contribution - 15 - - - 15

Dividends (note 12) - - (20,000) - - (20,000)

At 31 December 2016 176,238 134,301 64,627 (1,089) (244) 373,833

Company

Share

capital

$’000

Share

premium

$’000

Retained

earnings

$’000

Reval-

uation

reserve

$’000

Total

$’000

At 1 January 2015 176,238 134,286 11,690 757 322,971

Profit for the period (note 33) - - 48,495 - 48,495

Loss on revaluation of

investments – AFS - - - (1,562) (1,562)

Deferred tax on revaluation of

investments – AFS - - - 312 312

At 31 December 2015

and 1 January 2016

176,238

134,286

60,185

(493)

370,216

Profit for the period (note 33) - - 993 - 993

Loss on revaluation of

investments – AFS - - - (31) (31)

Deferred tax on revaluation of

investments – AFS - - - 10 10

Dividends (note 12) - - (20,000) - (20,000)

At 31 December 2016 176,238 134,286 41,178 (514) 351,188

The notes on pages 33 to 85 form part of these financial statements.

Page 32: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

31

CASH FLOW STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016

Group Company

Notes

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Profit before tax 27,007 17,619 1,014 48,345

Adjustment to reconcile profit

before tax to net cash flows:

Depreciation of property, plant and

equipment 6, 15 2,535 4,098 - -

Amortisation of other intangible assets 6, 14 389 606 - -

Impairment of subsidiaries 16(b) - - - 38,146

Impairment of Goodwill 9, 13 - 3,000 - -

Movement in financial instruments –

fair value through profit or loss 5 4 - -

Foreign exchange adjustment / on

other assets - 51 - -

(Decrease) / increase in provisions 27 (1,148) 210 - -

Interest received (1,210) (282) (320) (262)

Interest paid 1,964 1,721 - -

Operating cash flows before changes

in working capital

29,542

27,027

694

86,229

Working capital adjustments:

Decrease / (increase) in trade and other

receivables 2,098 (92,695) 26,958 (26,948)

Increase / (decrease) in trade and other

payables 206 148,357 992 (52,663)

Decrease / (increase) in inventory 15,870 (15,870) - -

(Increase) / decrease in derivative

instruments – assets (19,076) 7,246 - -

Increase / (decrease) in derivative

instruments – liabilities 8,485 (6,710) - -

Increase in financial assets – held to

maturity (685) (59,534) - -

Cash inflow from operating

activities

36,440

7,821

28,644

6,618

The notes on pages 33 to 85 form part of these financial statements.

Page 33: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

32

CASH FLOW STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

Group Company

Notes

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Corporation tax (paid) / received (6,342) 142 (94) (507)

Net cash inflow from operating

activities

30,098

7,963

28,550

6,111

Investing activities

Purchase of property, plant and

equipment 15 (1,257) (831) - -

Purchase of intangible assets 14 (155) (466) - -

Increase in investment in group

undertakings 16(b) - - - (7,305)

Net cash outflow from investing

activities

(1,412)

(1,297)

-

(7,305)

Financing activities

(Decrease) / increase in repurchase

agreements (18,938) 18,938 - -

Increase / (decrease) in short-term

borrowings 40,000 (25,000) - -

(Increase) / decrease in subordinated

loans to group undertakings - - (8,500) 1,000

Decrease in other assets 908 - - -

Interest received 1,210 282 320 262

Interest paid (1,964) (1,721) - -

Increase in capital contribution 15 - - -

Dividends paid (20,000) - (20,000) -

Net cash inflow / (outflow) from

financing activities

1,231

(7,501)

(28,180)

1,262

Net increase / (decrease) in cash and

cash equivalents

29,917

(835)

370

68

Cash and cash equivalents

Cash available on demand and short-

term deposits at 1 January 158,261 159,096 116 48

Increase / (decrease) in cash 29,917 (835) 370 68

Cash and cash equivalents

at 31 December

188,178

158,261

486

116

The notes on pages 33 to 85 form part of these financial statements.

Page 34: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

33

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016

1. GENERAL INFORMATION

Marex Spectron Group Limited (‘the Company’) is a company incorporated in England and Wales under the

Companies Act. The address of the registered office is 155 Bishopsgate, London EC2M 3TQ. The principal

activities of the Group and the nature of the Group’s operations are set out in note 5 and in the Strategic

Report.

The Group and company financial statements are presented in US Dollars (‘USD’) which is also the currency

of the primary economic environment in which the Group operates. Foreign operations are included in

accordance with the policies set out in note 3(k).

2. ADOPTION OF NEW AND REVISED STANDARDS

(a) Amendments to IFRSs and the new Interpretations that are mandatorily effective for the

current year

In the current year, the Group has applied a number of amendments to IFRSs and a new Interpretation issued

by the International Accounting Standards Board (‘IASB’) that are mandatorily effective for an accounting

period that begins on or after 1 January 2016. Their adoption has not had any material impact on the

disclosures or on the amounts reported in these financial statements.

▪ Amendments to IFRS 10, IFRS 12 and IAS 28 Investment Entities

The Group has adopted the amendments to IFRS 10, IFRS 12 and IAS 28 Investment Entities: Applying the

Consolidation Exception for the first time in the current year. The amendments clarify that the exemption

from preparing consolidated financial statements is available to a parent entity that is a subsidiary of an

investment entity, even if the investment entity measures all its subsidiaries at fair value in accordance with

IFRS 10. The amendments also clarify that the requirement for an investment entity to consolidate a

subsidiary providing services related to the former’s investment activities applies only to subsidiaries that are

not investment entities themselves.

As the Company is not an investment entity (assessed based on the criteria set out in IFRS 10 as at 1 January

2016), the adoption of the amendments has had no impact on the disclosures or on the amounts recognised in

the Group’s consolidated financial statements.

▪ Amendments to IFRS 11 Accounting for Acquisitions of Interests in Joint Operations

The Group has adopted the amendments to IFRS 11 Accounting for Acquisitions of Interests in Joint

Operations for the first time in the current year. The amendments provide guidance on how to account for

the acquisition of a joint operation that constitutes a business as defined in IFRS 3 Business Combinations.

Specifically, the amendments state that the relevant principles on accounting for business combinations in

IFRS 3 and other standards should be applied. The same requirements should be applied to the formation of

a joint operation if and only if an existing business is contributed to the joint operation by one of the parties

that participate in the joint operation.

A joint operator is also required to disclose the relevant information required by IFRS 3 and other standards

for business combinations.

The adoption of these amendments has had no impact on the Group's consolidated financial statements.

▪ Amendments to IAS 1 Disclosure Initiative

The Group has adopted the amendments to IAS 1 Disclosure Initiative for the first time in the current year.

The amendments clarify that an entity need not provide a specific disclosure required by an IFRS if the

information resulting from that disclosure is not material, and give guidance on the bases of aggregating and

disaggregating information for disclosure purposes. However, the amendments reiterate that an entity should

consider providing additional disclosures when compliance with the specific requirements in IFRS is

insufficient to enable users of financial statements to understand the impact of particular transactions, events

and conditions on the entity’s financial position and financial performance.

Page 35: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

34

2. ADOPTION OF NEW AND REVISED STANDARDS (CONTINUED)

(a) Amendments to IFRSs and the new Interpretations that are mandatorily effective for the

current year (continued)

▪ Amendments to IAS 1 Disclosure Initiative (continued)

In addition, the amendments clarify that an entity’s share of the other comprehensive income of associates

and joint ventures accounted for using the equity method should be presented separately from those arising

from the Group, and should be separated into the share of items that, in accordance with other IFRSs: (i) will

not be reclassified subsequently to profit or loss; and (ii) will be reclassified subsequently to profit or loss

when specific conditions are met.

The amendments also address the structure of the financial statements by providing examples of systematic

ordering or grouping of the notes.

▪ Amendments to IAS 16 and IAS 38 Clarification of Acceptable Methods of Depreciation and

Amortisation

The Group has adopted the amendments to IAS 16 and IAS 38 Clarification of Acceptable Methods of

Depreciation and Amortisation for the first time in the current year. The amendments to IAS 16 prohibit

entities from using a revenue-based depreciation method for items of property, plant and equipment. The

amendments to IAS 38 introduce a rebuttable presumption that revenue is not an appropriate basis for

amortisation of an intangible asset. This presumption can only be rebutted in the following two limited

circumstances:

▪ when the intangible asset is expressed as a measure of revenue; or

▪ when it can be demonstrated that revenue and consumption of the economic benefits of the

intangible asset are highly correlated.

As the Group already uses the straight-line method for depreciation and amortisation for its property, plant

and equipment and intangible assets, respectively, the adoption of these amendments has had no impact on

the Group's consolidated financial statements.

▪ Amendments to IAS 16 and IAS 41 Agriculture: Bearer Plants

The Group has adopted the amendments to IAS 16 and IAS 41 Agriculture: Bearer Plants for the first time in

the current year. The amendments define a bearer plant and require biological assets that meet the definition

of a bearer plant to be accounted for as property, plant and equipment in accordance with IAS 16, instead of

IAS 41. The produce growing on bearer plants continues to be accounted for in accordance with IAS 41.

The adoption of these amendments has had no impact on the Group’s consolidated financial statements as

the Group is not engaged in agricultural activities.

▪ Amendments to IAS 27 Equity Method in Separate Financial Statements

The Group has adopted the amendments to IAS 27 Equity Method in Separate Financial Statements for the

first time in the current year. The amendments focus on separate financial statements and allow the use of

the equity method in such statements. Specifically, the amendments allow an entity to account for

investments in subsidiaries, joint ventures and associates in its separate financial statements:

▪ at cost;

▪ in accordance with IFRS 9 (or IAS 39 for entities that have not yet adopted IFRS 9); or

▪ using the equity method as described in IAS 28 Investments in Associates and Joint Ventures.

The same accounting must be applied to each category of investments.

The amendments also clarify that when a parent ceases to be an investment entity, or becomes an investment

entity, it should account for the change from the date when the change in status occurs.

The adoption of the amendments has had no impact on the Company’s separate financial statements as the

Company accounts for investments in subsidiaries and associates at cost and is not an investment entity.

Page 36: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

35

2. ADOPTION OF NEW AND REVISED STANDARDS (CONTINUED)

(a) Amendments to IFRSs and the new Interpretations that are mandatorily effective for the

current year (continued)

▪ Annual Improvements to IFRSs 2012-2014 Cycle

The Group has adopted the amendments to IFRSs included in the Annual Improvements to IFRSs 2012-2014

Cycle for the first time in the current year.

The amendments to IFRS 5 introduce specific guidance in IFRS 5 for when an entity reclassifies an asset (or

disposal group) from held for sale to held for distribution to owners (or vice versa). The amendments clarify

that such a change should be considered as a continuation of the original plan of disposal and hence

requirements set out in IFRS 5 regarding the change of sale plan do not apply. The amendments also

clarifies the guidance for when held-for-distribution accounting is discontinued.

The amendments to IFRS 7 provide additional guidance to clarify whether a servicing contract is continuing

involvement in a transferred asset for the purpose of the disclosures required in relation to transferred assets.

The amendments to IAS 19 clarify that the rate used to discount post-employment benefit obligations should

be determined by reference to market yields at the end of the reporting period on high quality corporate

bonds. The assessment of the depth of a market for high quality corporate bonds should be at the currency

level (i.e. the same currency as the benefits are to be paid). For currencies for which there is no deep market

in such high quality corporate bonds, the market yields at the end of the reporting period on government

bonds denominated in that currency should be used instead.

The adoption of these amendments has had no effect on the Group’s consolidated financial statements.

(b) New and revised IFRSs in issue, but not yet effective

At the date of authorisation of these financial statements, the Group has not applied the following new and

revised IFRSs that have been issued, but are not yet effective and, in some cases, had not yet been adopted

by the EU:

IFRS 9 Financial Instruments

IFRS 15 Revenue from Contracts with Customers

IFRS 16 Leases

IFRS 2 (amendments) Clarification and Measurement of Share-based Payment Transactions

IAS 7 (amendments) Disclosure Initiative

IAS 12 (amendments) Recognition of Deferred Tax Assets for Unrealised Losses

IFRS 10 and IAS 28

(amendments)

Sale or Contribution of Assets between an Investor and its Associate or

Joint Venture

The directors do not expect that the adoption of the Standards listed above will have a material impact on the

financial statements of the Group in future periods, except as noted below:

▪ IFRS 9 will impact both the measurement and disclosures of financial instruments;

▪ IFRS 15 may have an impact on revenue recognition and related disclosures; and

▪ IFRS 16 will have a material impact on the reported assets, liabilities, income statement and

cash flows of the Group. Furthermore, extensive disclosures will be required by IFRS 16.

Beyond the information above, it is not practicable to provide a reasonable estimate of the effect of these

standards until a detailed review has been completed.

Page 37: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

36

3. SIGNIFICANT ACCOUNTING POLICIES

(a) Basis of accounting

The consolidated financial statements of the Group and the standalone financial statements of Marex

Spectron Group Limited have been prepared in accordance with International Financial Reporting Standards

(‘IFRS’) as issued by the International Accounting Standards Board (‘IASB’) as well as interpretations

issued by the IFRS Interpretations Committee (‘IFRIC’) as endorsed by the European Union (‘EU’).

The Company has taken the exemption in section 408(3) of the Companies Act 2006 not to present a

standalone income statement, standalone statement of comprehensive income and related notes that form a

part of the financial statements.

The financial statements have been prepared on the historical cost basis, except for the revaluation of certain

financial instruments that are measured at revalued amounts or fair values at the end of each reporting

period, as explained in the accounting policies below. Historical cost is generally based on the fair value of

the consideration given in exchange for goods and services.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly

transaction between market participants at the measurement date, regardless of whether that price is directly

observable or estimated using another valuation technique. In estimating the fair value of an asset or a

liability, the Group takes into account the characteristics of the asset or liability if market participants would

take those characteristics into account when pricing the asset or liability at the measurement date. Fair value

for measurement and/or disclosure purposes in these consolidated financial statements is determined on such

a basis, except for share-based payment transactions that are within the scope of IFRS 2, leasing transactions

that are within the scope of IAS 17, and measurements that have some similarities to fair value but are not

fair value, such as net realisable value in IAS 2 or value in use in IAS 36.

In addition, for financial reporting purposes, fair value measurements are categorised into Level 1, 2 or 3

based on the degree to which the inputs to the fair value measurements are observable and the significance of

the inputs to the fair value measurement in its entirety, which are described as follows:

▪ Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the

entity can access at the measurement date;

▪ Level 2 inputs are inputs, other than quoted prices included within Level 1, that are observable for the

asset or liability, either directly or indirectly; and

▪ Level 3 inputs are unobservable inputs for the asset or liability.

The principal accounting policies adopted are set out below.

Page 38: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

37

3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(b) Basis of consolidation

The consolidated financial statements incorporate the financial statements of the Company and entities

controlled by the Company (‘its subsidiaries’) made up to 31 December each year. Control is achieved when

the Company:

▪ has the power over the investee;

▪ is exposed, or has rights, to variable return from its involvement with the investee; and

▪ has the ability to use its power to affect its returns.

The Company reassesses whether or not it controls an investee if facts and circumstances indicate that there

are changes to one or more of the three elements of control listed above.

Consolidation of a subsidiary begins when the Company obtains control over the subsidiary and ceases when

the Company losses control of the subsidiary. Specifically, the results of subsidiaries acquired or disposed of

during the year are included in the consolidated income statement from the date the Company gains control

until the date when the Company ceases to control the subsidiary.

Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting

policies used into line with the Group’s accounting policies.

All intragroup assets and liabilities, equity, income, expenses and cash flows relating to transactions between

the members of the Group are eliminated on consolidation.

(c) Going concern

The directors have, at the time of approving the financial statements, a reasonable expectation that the

Company and the Group have adequate resources to continue in operational existence for the foreseeable

future. Thus they continue to adopt the going concern basis of accounting in preparing the financial

statements.

(d) Business combinations

Acquisitions of subsidiaries and businesses are accounted for using the acquisition method. The

consideration transferred in a business combination is measured at fair value, which is calculated as the sum

of the acquisition-date fair values of assets transferred by the Group, liabilities incurred by the Group to the

former owners of the acquiree and the equity interest issued by the Group in exchange for control of the

acquiree. Acquisition-related costs are recognised in profit or loss as incurred.

At the acquisition date, the identifiable assets acquired and the liabilities assumed are recognised at their fair

value at the acquisition date, except that:

▪ deferred tax assets or liabilities and assets or liabilities related to employee benefit arrangements are

recognised and measured in accordance with IAS 12 Income Taxes and IAS 19 Employee Benefits

respectively; and

▪ assets (or disposal groups) that are classified as held for sale in accordance with IFRS 5 Non-current

Assets Held for Sale and Discontinued Operations are measured in accordance with that Standard.

Goodwill arises on the acquisition of subsidiaries and represents the excess of the cost of the acquisition

(including the fair value of deferred and contingent consideration) of a business combination, over the share

in the fair value of identifiable assets, liabilities and contingent liabilities acquired. Cost comprises the fair

values of assets given, liabilities assumed and equity instruments issued, plus any direct costs of acquisition.

Page 39: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

38

3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(e) Goodwill

Goodwill is initially recognised and measured as set out above.

Goodwill has an indefinite useful economic life and is measured at cost less any accumulated impairment

losses. It is tested for impairment annually and whenever there is an indicator of impairment. Where the

carrying value exceeds the higher of the value in use or fair value less cost to sell, an impairment loss is

recognised in the income statement.

(f) Revenue recognition

Revenue is recognised when it is probable that the economic benefits will flow to the Group and the revenue

can be reliably measured. Revenue is measured at the fair value of the consideration received or receivable

taking into account any trade discounts and volume rebates granted by the Group.

Revenue comprises the following:

▪ execution and clearing commissions, which are recognised on a trade date basis;

▪ metals trading and broking, energy broking and foreign exchange trading activity where the Group acts

as principal, which is typically recognised on a fair value basis whereby movements in fair values of

the position are recognised in the income statement;

▪ desk facilities, licence and software fees, and market data fees which are recognised on an accruals

basis; and

▪ net interest directly relating to the trading activities of the Group are recognised on an accruals basis.

Other income primarily comprises exchange rebates and is recognised on an accruals basis.

In accordance with accepted practice, those financial instruments held for trading purposes are fair valued

and subsequent gains and losses are recognised in the income statement.

(g) Dividend income

Dividend income from investments is recognised when the shareholder’s rights to receive payment have

been established (provided that it is probable that the economic benefits will flow to the Group and the

amount of revenue can be measured reliably).

(h) Finance income and expense

Finance income is earned on balances held at exchanges, clearing houses, banks and brokers, and on

overdrawn client balances. Finance expenses are paid on overdrawn accounts with brokers and exchanges,

client and counterparty balances and short-term borrowings. Finance income and expenses are recognised on

an amortised cost basis using the effective interest rate (‘EIR’) method.

(i) Leases

Rentals payable under operating leases are charged to income on a straight-line basis over the term of the

relevant lease except where another more systematic basis is more representative of the time pattern in which

economic benefits from the lease asset are consumed.

In the event that lease incentives are received to enter into operating leases, such incentives are recognised as

a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-

line basis over the lease term, except where another systematic basis is more representative of the time

pattern in which economic benefits from the leased asset are consumed.

Page 40: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

39

3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(j) Borrowing costs

Borrowing costs consist of interest and other costs that are incurred in connection with the borrowing of

funds and are expensed in the income statement over the period of the borrowing facility.

(k) Foreign currency translation

The Group and Company financial statements are presented in US Dollars (‘USD’), which is also the

currency of the primary economic environment (the functional currency) and the presentational currency of

the Group.

For each entity, the Group determines the functional currency and items included in the financial statements

of each entity are measured using that functional currency.

Transactions entered into by Group entities in a currency other than USD are recorded at the rates prevailing

when the transactions occur. Foreign currency monetary assets and liabilities are translated at the rates

prevailing at the reporting date. Exchange differences arising on the retranslation of monetary assets and

liabilities are similarly recognised immediately in the income statement.

On consolidation, the results of overseas operations are translated into USD at rates approximating to those

prevailing when the transactions took place. All assets and liabilities of overseas operations, including

goodwill arising on the acquisition of those operations, are translated at the rates ruling at the prevailing date.

(l) Employee benefits

Short-term employee benefits

Short-term employee benefits are expensed as the related service is provided. A liability is recognised for

the amount expected to be paid if the Group has a present legal or constructive obligation to pay this amount

as a result of past service provided by the employee and the obligation can be estimated reliably.

Retirement benefits: defined contribution schemes

The Group operates defined contribution schemes. Payments to defined contribution retirement benefit

schemes are recognised as an expense when employees have rendered services entitling them to

contributions.

Page 41: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

40

3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(m) Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as

reported in the income statement because it excludes items of income or expense that are taxable or

deductible in other years and it further excludes items that are never taxable or deductible. The Group’s

liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the

balance sheet date.

Deferred tax

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of

assets and liabilities in the financial statements and the corresponding tax bases used in the computation of

taxable profit, and is accounted for using the balance sheet liability method. Deferred tax liabilities are

generally recognised for all taxable temporary differences and deferred tax assets are recognised to the extent

that it is probable that taxable profits will be available against which deductible temporary differences can be

utilised. Such assets and liabilities are not recognised if the temporary difference arises from the initial

recognition of goodwill or from the initial recognition (other than in a business combination) of other assets

and liabilities in a transaction that affects neither the taxable profit nor the accounting profit.

Deferred tax liabilities are recognised for taxable temporary differences arising on investments in

subsidiaries and associates, and interests in joint ventures, except where the Group is able to control the

reversal of the temporary difference and it is probable that the temporary difference will not reverse in the

foreseeable future. Deferred tax assets arising from deductible temporary differences associated with such

investments and interests are only recognised to the extent that it is probable that there will be sufficient

taxable profits against which to utilise the benefits of the temporary differences and they are expected to

reverse in the foreseeable future.

The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent

that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to

be recovered.

Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled

or the asset is realised based on tax laws and rates that have been enacted or substantively enacted at the

balance sheet date. Deferred tax is charged or credited in the income statement, except when it relates to

items charged or credited in other comprehensive income, in which case the deferred tax is also dealt with in

other comprehensive income.

The measurement of deferred tax liabilities and assets reflects the tax consequences that would follow from

the manner in which the Group expects, at the end of the reporting period, to recover or settle the carrying

amount of its assets and liabilities.

Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax

assets against current tax liabilities and when they relate to income taxes levied by the same taxation

authority and the Group intends to settle its current tax assets and liabilities on a net basis.

Current tax and deferred tax for the year

Current and deferred tax are recognised in profit or loss, except when they relate to items that are recognised

in other comprehensive income or directly in equity, in which case, the current and deferred tax are also

recognised in other comprehensive income or directly in equity respectively. Where current tax or deferred

tax arises from the initial accounting for a business combination, the tax effect is included in the accounting

for the business combination.

Page 42: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

41

3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(n) Property, plant and equipment

Property, plant and equipment are stated at cost, net of accumulated depreciation and any accumulated

impairment losses.

As well as the purchase price, cost includes the directly attributable costs and the estimated present value of

any future costs of dismantling and removing items. The corresponding liability is recognised within

provisions.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over

their useful lives, using the straight-line method, on the following bases:

Leasehold improvements over the remaining length of the lease or

20% per annum straight-line, where appropriate

Furniture, fixtures and fittings 20% to 50% per annum straight-line

Computer equipment 20% to 50% per annum straight-line

Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted if

appropriate.

An item of property, plant and equipment is derecognised upon disposal or when no future economic benefits

are expected to arise from the continued use of the asset. The gain or loss arising on the disposal or

scrappage of an asset is determined as the difference between the sales proceeds and the carrying amount of

the asset and is recognised in the income statement.

(o) Other intangible assets

Internally generated intangible assets (software development costs)

Expenditure on internally generated intangible assets is only capitalised if it can be demonstrated that:

▪ it is technically feasible to develop the product for it to be available for use or sold;

▪ adequate resources are available to complete the development;

▪ there is an intention to complete and use or sell the product;

▪ the Group is able to use or sell the product;

▪ use or sale of the product will generate future economic benefits; and

▪ expenditure on the project can be measured reliably.

Capitalised development costs are measured at cost less any accumulated amortisation and any accumulated

impairment losses. Amortisation is calculated on a straight-line basis over estimated economic useful lives

of 2 to 5 years, which represents the period that the Group expects to benefit from using or selling the

products developed, and is recognised in the income statement.

The amount initially recognised for internally generated intangible assets is the sum of the expenditure

incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no

internally generated asset can be recognised development expenditure is recognised in profit and loss in the

period in which it is incurred.

Software licences

Software licences have a finite useful economic life of 2 to 5 years with the option of renewal at the end of

this period. They are amortised in the consolidated income statement on a straight-line basis over the period

of the licence.

An intangible asset is derecognised on disposal, or when no future economic benefits are expected from use

or disposal. Gains or losses arising from derecognition of an intangible asset, measured as the difference

between the net disposal proceeds and the carrying amount of the asset, are recognised in the consolidated

income statement when the asset is derecognised.

Page 43: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

42

3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(p) Impairment of non-financial assets

Impairment tests on goodwill and other intangible assets with indefinite useful lives are undertaken annually.

Other non-financial assets are subject to impairment tests whenever events or changes in circumstances

indicate that their carrying amount may not be recoverable.

The recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value

in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that

reflects current market assessments of the time value of money and risks specific to the asset for which the

estimates of future cash flows have not been adjusted.

The impairment test is carried out on the asset’s cash generating unit (i.e. the smallest group of assets in

which the asset belongs for which there are separately identifiable cash flows).

An impairment loss in respect of goodwill is not reversed. For other assets, an impairment loss is reversed

only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been

determined, net of depreciation or amortisation, if no impairment loss had been recognised.

Where the carrying value of an asset exceeds its recoverable amount an impairment loss is recognised in the

income statement.

(q) Financial instruments

Financial assets and financial liabilities are recognised in the Group’s balance sheet when the Group

becomes a party to the contractual provisions of the instrument.

Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are

directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial

assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value

of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly

attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are

recognised immediately in profit or loss.

Effective interest method

The effective interest rate method is a method of calculating the amortised cost of a financial instrument and

allocating interest income or expense over the relevant period. The effective interest rate (‘EIR’) is the rate

that exactly discounts estimated future cash receipts (including all fees and points paid or received that form

an integral part of the effective interest rate, transaction costs and other premiums or discounts) through the

expected life of the financial instrument, or, where appropriate, a shorter period, to the net carrying amount

on initial recognition.

Financial assets

All financial assets are recognised and derecognised on a trade date where the purchase or sale of a financial

asset is under a contract whose terms require delivery of the financial asset within the timeframe established

by the market concerned, and are initially measured at fair value, plus transaction costs, except for those

financial assets classified as at fair value through profit or loss, which are initially measured at fair value.

Page 44: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

43

3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(q) Financial instruments (continued)

Financial assets (continued)

Income is recognised on an effective interest basis for debt instruments other than those financial assets

classified as at fair value through profit or loss (‘FVTPL’).

Financial assets are classified into the following specified categories depending on the nature and purpose of

the financial assets and is determined at the time of initial recognition.

▪ Fair value through profit or loss: this category includes financial assets held for trading. They are

carried in the balance sheet at fair value with changes in fair value recognised in the income statement.

▪ Loans and receivables: these assets are non-derivative financial assets with fixed or determinable

payments that are not quoted in an active market. They arise principally through the provision of

goods and services to customers (‘trade debtors’), but also incorporate other types of contractual

monetary assets. They are carried at amortised cost using the EIR method less provision for any

impairment.

▪ Available-for-sale: these assets comprise the Group’s strategic investments in entities not qualifying as

subsidiaries, associates or jointly controlled entities, and investments in memberships, seats and

interests in investment exchanges. They are carried at fair value with changes in fair value recognised

in other comprehensive income. Fair values of quoted investments are based on current prices. If the

market for a financial asset is not active and for unlisted securities, the Group establishes fair value by

using the latest available trade price adjusted as necessary to reflect current market conditions.

▪ Held to maturity: held to maturity investments are financial assets with fixed or determinable payments

and fixed maturities where the Group has the intention and ability to hold to maturity. These assets are

measured at amortised cost, using the effective interest method less any impairment. The amortisation

is included in the income statement.

Derecognition of financial assets

The Group derecognises a financial asset only when the contractual rights to the cash flows from the asset

expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership of the

asset to another entity.

Financial liabilities

Financial liabilities are classified as either financial liabilities at ‘FVTPL’ or ‘other financial liabilities’.

The Group classifies its financial liabilities into the following categories, depending on the purpose for

which the liability was assumed. The Group’s accounting policy for each category is as follows:

▪ Fair value through profit or loss (‘FVTPL’): this category includes financial instruments held for

trading. They are carried in the balance sheet at fair value with changes in fair value recognised in the

income statement.

▪ Other financial liabilities: other financial liabilities include the following items:

▪ trade and other payables and other short-term monetary liabilities which are recognised at

amortised cost; and

▪ bank borrowings, such interest-bearing liabilities are subsequently measured at amortised cost

using the EIR method, which ensures that any interest expense over the period to repayment is

recognised at a constant rate on the balance of the liability carried in the statement of financial

position.

Page 45: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

44

3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(q) Financial instruments (continued)

Derecognition of financial liabilities

A financial liability is derecognised when the obligation under the liability is discharged, cancelled or

expires. In circumstances where a financial liability is replaced by the same lender yet the contractual terms

are substantially different or modified, the original financial liability will be derecognised at the point of

contractual exchange and the new financial liability recognised.

Offsetting of financial assets and liabilities

Financial assets and liabilities are offset and the net amount is reported in the statement of financial position

if there is a currently enforceable legal right to offset the recognised amounts and there is an intention and

ability to settle on a net basis, or to realise the assets and liabilities simultaneously.

Specific instruments

▪ Secured payables under repurchase agreements

When the Group sells a financial asset and simultaneously enters into an agreement to repurchase the same

or a similar asset at a fixed price on a future date (a repurchase agreement), the arrangement is accounted for

as borrowings and recognised in the statement of financial position as a payable under a repurchase

agreement. The underlying asset continues to be recognised in the Group’s financial statements.

Secured payables under repurchase agreements are subsequently measured at amortised cost.

▪ Derivative instruments

Derivative assets and derivative liabilities at fair value through profit or loss comprise of over-the-counter

foreign exchange and precious metal contracts. These are entered to hedge over-the-counter foreign

exchange and precious metal contracts transacted between the Group and their customers.

▪ Inventories

The Group holds physical metal, in the form of London Metal Exchange warrants. Inventories are held for

trading with the purpose of selling in the near term and carried at fair value with the changes in fair value

recognised in the consolidated income statement.

(r) Impairment of financial assets

The Group assesses at each reporting date, whether there is objective evidence that a financial asset or group

of financial assets, other than those at fair value through profit or loss, are impaired. An impairment exists if

one or more events that has occurred since initial recognition of the financial asset (an incurred ‘loss event’),

has an impact on the estimated future cash flows of the financial asset or group of financial assets that can be

reliably measured.

For listed and unlisted equity investments classified as available-for-sale, a significant or prolonged decline

in the fair value of the security below its cost is considered to be objective evidence of impairment.

When an available-for-sale asset is considered to be impaired, cumulative gains or losses previously

recognised in other comprehensive income are reclassified to profit or loss in the period.

For all other financial assets, objective evidence of impairment could include:

▪ debtors or a group of debtors experiencing significant difficulties, or there is high probability they will

enter bankruptcy;

▪ default or delinquency in interest or principal payments; and / or

▪ significant financial difficulty of the issuer or counterparty.

Page 46: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

45

3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(s) Provisions

Provisions are recognised when the Group has a present obligation (legal or constructive) as a result of a past

event, it is probable that the Group will be required to settle that obligation and a reliable estimate can be

made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present

obligation at the balance sheet date, taking into account the risks and uncertainties surrounding the

obligation.

When some or all of the economic benefits required to settle a provision are expected to be recovered from a

third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received

and the amount of the receivable can be measured reliably.

Onerous contracts

Present obligations arising under onerous contracts are recognised and measured as provisions. An onerous

contract is considered to exist where the Group has a contract under which the unavoidable costs of meeting

the obligations under the contract exceed the economic benefits expected to be received under it.

(t) Cash and cash equivalents

Cash and cash equivalents in the statement of financial position comprise cash at banks and on hand, and

short-term deposits.

(u) Cash and non-cash distributions

The Company recognises a liability to make cash or non-cash distributions to its equity holders when the

distribution is authorised and the distribution is no longer at the discretion of the Company. As per the

corporate laws in the United Kingdom, a distribution is authorised when it is approved by the shareholders.

A corresponding amount is recognised directly in equity.

Non-cash distributions are measured at the fair value of the assets to be distributed with fair value re-

measurement recognised directly in equity. Upon distribution of non-cash assets, any difference between the

carrying amount of the liability and the carrying amount of the assets distributed is recognised in the

consolidated income statement.

(v) Client money

As required by the UK FCA’s Client Assets Sourcebook (‘CASS’) rules and the CFTC’s client money rules,

the Group maintains certain balances on behalf of clients with banks, exchanges, clearing houses and brokers

in segregated accounts. These amounts and the related liabilities to clients, whose recourse is limited to

segregated accounts, are not included in the statement of financial position as the Group is not beneficially

entitled thereto.

Page 47: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

46

4. CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS

In the application of the Group’s accounting policies, which are described in note 3, the directors are

required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities

that are not readily apparent from other sources. The estimates and associated assumptions are based on

historical experience and other factors that are considered to be relevant. Actual results may differ from

these estimates.

The estimates and underlying assumptions are reviewed on an on-going basis and revisions to accounting

estimates are recognised in the period in which the estimate is revised. Significant judgement and estimates

are necessary in relation to the following matters:

(a) Impairment of non-financial assets

The Group’s impairment testing for goodwill and non-financial assets with indefinite useful lives is based on

the fair value less costs of disposal. The fair value less costs of disposal calculation is based on available

data from similar assets or observable market prices less incremental costs for disposing of the assets and is

estimated by using the EBITDA multiples derived from adjusting comparative peer multiples. This multiple

is applied to the most recent Board approved financial budgets.

(b) Fair value of financial instruments

The Group determines the fair value of financial instruments that are not quoted, based on estimates using

present values or other valuation techniques. Those techniques are significantly affected by the assumptions

used, including discount rates and estimates of future cash flows. Where market prices are not readily

available, fair value is either based on estimates obtained from independent experts or quoted market prices

of comparable instruments. In that regard, the derived fair value estimates cannot be substantiated by

comparison with independent markets and, in many cases, may not be capable of being realised immediately.

(c) Useful lives of intangible assets and property, plant and equipment

Intangible assets and property, plant and equipment are amortised or depreciated over their useful economic

lives. Useful economic lives are based on estimates of the period that the assets will generate revenue, which

are periodically reviewed for continued appropriateness. Changes to estimates can result in significant

variations in the carrying value and amounts charged to the consolidated income statement in specific

periods.

(d) Provisions

The Group determines the provisions based on management’s assessment of relevant information and advice

available at the time of preparing the financial statements. Outcomes are uncertain and dependent on future

events. Where outcomes differ from management’s expectations, differences from the amount initially

provided are reflected in the consolidated income statement in the period the outcome it determined.

(e) Taxation

The Group calculates its current and deferred tax assets and liabilities based on management’s assessment of

relevant information and advice. Where outcomes differ from the amounts initially provided the difference

is reflected in the consolidated income statement in the period the outcome it determined.

Page 48: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

47

5. REVENUE

An analysis of the Group’s revenue is as follows:

Group

2016

$’000

2015

$’000

Execution and clearing commissions 269,661 285,184

Trading and broking 38,832 40,010

Desk facility and market data fees 11,004 12,012

Net interest income 3,499 2,951

Other income 7,374 7,590

330,370 347,747

Group

31 December 2016

North

America

$’000

Europe

$’000

Asia

$’000

Total

$’000

Commodities 39,865 172,017 23,004 234,886

Futures and Securities 7,406 15,460 - 22,866

Market Access - 69,358 - 69,358

Other 611 2,647 2 3,260

Revenue 47,882 259,482 23,006 330,370

Group

31 December 2015

North

America

$’000

Europe

$’000

Asia

$’000

Total

$’000

Commodities 37,536 179,670 18,627 235,833

Futures and Securities 5,715 24,612 - 30,327

Market Access - 80,035 - 80,035

Other 714 838 - 1,552

Revenue 43,965 285,155 18,627 347,747

Page 49: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

48

6. OPERATING PROFIT

This has been arrived at after charging:

Group

Notes

2016

$’000

2015

$’000

Staff costs 8 159,970 167,069

Depreciation of property, plant and equipment 15 2,535 4,098

Amortisation of other intangible assets 14 389 606

Charges under operating leases 30 7,335 10,412

Provision for bad and doubtful debts 22(b) 126 46

Foreign exchange (gains) / losses (393) 510

7. AUDITOR’S REMUNERATION

Group

2016

$’000

2015

$’000

Audit of the Group’s annual accounts 157 172

Audit of the Company’s subsidiaries 695 723

Total audit fees 852 895

Fees payable to the Group’s auditor for other

services comprise:

Audit-related assurance services 122 74

Tax compliance services 9 -

Tax advisory services 28 -

Other assurance services - 2

Other services 37 -

Total non-audit fee 196 76

Audit fees for the Group for the year ended 31 December 2016 and the prior year were paid by a group

undertaking.

Page 50: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

49

8. STAFF COSTS

Group

2016

Number

2015

Number

Front Office 275 307

Control & Support 225 217

Average monthly number of staff 500 524

Group

2016

$’000

2015

$’000

Aggregate wages and salaries 141,689 148,224

Employer’s National Insurance Contributions and

similar taxes

14,524

14,878

Short-term monetary benefits 2,540 2,660

Defined pension contribution cost 1,217 1,307

Total staff costs 159,970 167,069

As at 31 December 2016, there were contributions totalling $171,119 (2015: $207,000) payable to the

defined contribution pension scheme by the Group.

9. OTHER INCOME AND EXPENSE

Group

2016

$’000

2015

$’000

Other income

Dividends received 24 50

Other 2 45

26 95

Group

Notes

2016

$’000

2015

$’000

Other expense

Leasehold dilapidations and provisions 27 876 (900)

Impairment of Goodwill 13 - (3,000)

876 (3,900)

Page 51: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

50

10. FINANCE INCOME AND EXPENSE

Group

2016

$’000

2015

$’000

Finance income

Bank interest receivable 388 129

Interest receivable on held to maturity investments 1,448 425

1,836 554

Group

2016

$’000

2015

$’000

Finance expense

Bank interest payable (2,057) (1,856)

(2,057) (1,856)

Included in bank interest expenses, above, are credit facility expenses of $1,137,196 (2015: $1,774,000).

For further details on the credit facility, refer to note 23.

11. TAXATION

(a) Tax charge / (credit)

Group

Notes

2016

$’000

2015

$’000

Current tax

UK and foreign corporation tax on profit for the year 5,737 4,395

Adjustment in respect of prior years 143 15

5,880 4,410

Deferred tax

Origination and reversal of temporary differences 1,433 983

Adjustment in respect of prior years – US losses (582) (5,012)

Adjustment in respect of prior years – other (216) (406)

25 635 (4,435)

Tax charge / (credit) for the year 11(b) 6,515 (25)

Page 52: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

51

11. TAXATION (CONTINUED)

(b) Reconciliation between tax charge / credit and profit before tax

The tax assessed for the year is higher (2015: lower) than the standard rate of corporation tax in the UK

20.00% (2015: 20.25%). The standard rate of corporation tax in the UK reduced from 21% to 20% from 1

April 2015. Accordingly, UK corporation tax for this accounting period has been calculated at 20.00% of

the estimated assessable profits for the period. Taxation for other jurisdictions is calculated at rates

prevailing in the relevant jurisdictions. Finance (No. 2) Act 2015 enacted reductions in the UK corporation

tax rate to 19% with effect from 1 April 2017 and 18% with effect from 1 April 2020. Finance Act 2016

enacted a further reduction in the UK corporation tax rate to 17% by 2020 and this reduction in the tax rate

will impact the current tax charge in future periods.

Group

Notes

2016

$’000

2015

$’000

Profit before tax 27,007 17,619

Expected tax expense based on the standard rate of

corporation tax in the UK of 20.00% (2015: 20.25%) 5,401 3,568

Explained by:

Effect of overseas tax rates 546 391

Expenses not deductible for tax purposes 745 1,422

Income not subject to tax (5) (11)

Tax losses not recognised for deferred tax purposes 315 62

Foreign exchange and other differences 168 (54)

Prior year adjustments (655) (5,403)

Tax charge / (credit) for the year 11(a) 6,515 (25)

(c) Amounts recognised in other comprehensive income

Amounts directly recognised in the consolidated statement of other comprehensive income relate to

available-for-sale financial assets. The amount recognised in 2016 is a deferred tax credit of $104,000

(2015: $379,000).

12. DIVIDENDS PAID AND PROPOSED

The Company declared and made a dividend payment of $20,000,000 during the year (2015: $nil).

Page 53: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

52

13. GOODWILL

Group

$’000

Cost

At 1 January 2015, 1 January 2016

and 31 December 2016 150,101

Accumulated impairment losses

At 1 January 2015 6,132

Impairment charges (note 9) 3,000

At 31 December 2015 and 31 December 2016 9,132

Net book value

At 31 December 2015 and 31 December 2016 140,969

(a) Goodwill impairment testing

For the purpose of impairment testing, goodwill has been allocated to the cash generating units (‘CGUs’)

which represent the level at which goodwill is monitored and managed:

Group

Energy

$’000

Agri-

culturals

$’000

Protrader

$’000

Total

$’000

At 31 December 2015 and 2016 126,311 11,416 3,242 140,969

The Group performed the annual impairment test as at 31 December 2016 and 2015. In assessing whether

impairment is required, the carrying value of the CGU is compared with the recoverable amount which is

determined by fair value less cost of disposal.

(b) Key assumptions

▪ The fair value less cost of disposal is determined by applying an earnings multiple to the future cash

flows of each CGU arising in future periods.

▪ The Group prepares the cash flow forecasts derived from the most recent Board approved financial

budgets for the next three years. As the Group performance is continuously monitored against budget

and subject to Board supervision, the cash flow forecasts are considered to be Level 2.

▪ The earnings (‘EBITDA’) multiples applied are derived from comparable peer multiples.

▪ Comparable peers are those which our stakeholders evaluate our performance against whilst the

multiples are obtained from third party market data providers. Whilst third party data considers this to

be a Level 1 input, management applies a level of judgement in determining the EBITDA mulitiple and

as such is considered to be a Level 2 input.

Page 54: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

53

14. OTHER INTANGIBLE ASSETS

Group

Software

development

$’000

Trademarks

$’000

Total

$’000

Cost

At 1 January 2015 8,135 46 8,181

Additions 466 - 466

At 1 January 2016 8,601 46 8,647

Additions 155 - 155

Disposals (2,089) - (2,089)

At 31 December 2016 6,667 46 6,713

Impairment provisions and

amortisation

At 1 January 2015 7,270 - 7,270

Charge for the year (note 6) 606 - 606

At 1 January 2016 7,876 - 7,876

Charge for the year (note 6) 389 - 389

Disposals (2,089) - (2,089)

At 31 December 2016 6,176 - 6,176

Net book value

At 31 December 2016 491 46 537

At 31 December 2015 725 46 771

Page 55: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

54

14. OTHER INTANGIBLE ASSETS (CONTINUED)

Company

Trademarks

$’000

Total

$’000

Cost

At 1 January 2015 and 1 January 2016 - -

Transferred in during the year 46 46

At 31 December 2016 46 46

Impairment provisions and

amortisation

At 1 January 2015, 1 January 2016

and 31 December 2016 - -

Net book value

At 31 December 2016 46 46

At 31 December 2015 - -

Trademarks of $45,534 were transferred to the Company from liquidation proceedings of EasyScreen

Limited during the year. EasyScreen Limited is a subsidiary held directly by the Company.

Page 56: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

55

15. PROPERTY, PLANT AND EQUIPMENT

Group

Leasehold

improve-

ments

$’000

Computer

expenses

$’000

Furniture,

fixtures and

fittings

$’000

Total

$’000

Cost

At 1 January 2015 8,858 20,443 4,544 33,845

Additions 181 603 47 831

Disposals (633) (3,089) (199) (3,921)

At 1 January 2016 8,406 17,957 4,392 30,755

Additions 333 918 6 1,257

Disposals (3,248) (2,525) (634) (6,407)

At 31 December 2016 5,491 16,350 3,764 25,605

Depreciation

At 1 January 2015 5,666 17,625 3,508 26,799

Charge for the year (note 6) 1,645 1,831 622 4,098

Disposals (633) (3,089) (199) (3,921)

At 1 January 2016 6,678 16,367 3,931 26,976

Charge for the year (note 6) 1,178 1,157 200 2,535

Disposals (3,248) (2,525) (634) (6,407)

At 31 December 2016 4,608 14,999 3,497 23,104

Net book value

At 31 December 2016 883 1,351 267 2,501

At 31 December 2015 1,728 1,590 461 3,779

Page 57: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

56

16. INVESTMENTS

(a) Available-for-sale investments

Group Company

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Cost

At 1 January 7,261 8,990 3,165 4,727

Revaluation (365) (1,729) (31) (1,562)

At 31 December 6,896 7,261 3,134 3,165

Listed investments 1,901 1,603 892 810

Unlisted investments 4,995 5,658 2,242 2,355

6,896 7,261 3,134 3,165

Investments comprise shares and seats held in clearing houses which are deemed relevant to the Group’s

trading activities and are classified as available-for-sale financial assets and recorded at fair value with

changes in fair value reported in equity. The fair value for these investments is determined as the latest

available traded price.

(b) Investments in subsidiaries

Company

2016

$’000

2015

$’000

Cost

At 1 January 331,722 362,563

Additions - 7,305

Impairment - (38,146)

At 31 December 331,722 331,722

Page 58: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

57

16. INVESTMENTS (CONTINUED)

(c) Group subsidiaries and undertakings

The subsidiaries of the Company as at 31 December 2016 are as follows:

Subsidiaries held directly

Name / Registered office

Country of

incorporation

/ Principal

place of

business Class

Proportion of

ownership

interest Nature of business

4GP Leases Limited

155 Bishopsgate, London,

EC2M 3TQ

England and

Wales

Ordinary

shares

100% Dormant

EasyScreen Limited

155 Bishopsgate, London,

EC2M 3TQ

England and

Wales

Ordinary

shares

100% Dormant

Marex Financial Limited

155 Bishopsgate, London,

EC2M 3TQ

England and

Wales

Ordinary

shares

100% Commodities and

financial

instruments

broker and clearer

Marex Hong Kong Limited

20/F Alexandra House, 16-

20 Chater Road, Central,

Hong Kong

Hong Kong Ordinary

shares

100% Futures and options

broking

Marex North America LLC

360 Madison Ave, Third

Floor, New York 10017

United States of

America

Membership

interest

100% Commodities and

financial

instruments

broker and clearer

Marex Spectron International

Limited 1

155 Bishopsgate, London,

EC2M 3TQ

England and

Wales

Ordinary

shares

100% Energy OTC

broking

Marex Services Limited

155 Bishopsgate, London,

EC2M 3TQ

England and

Wales

Ordinary

shares

100% Dormant

Marex USA Limited

155 Bishopsgate, London,

EC2M 3TQ

England and

Wales

Ordinary

shares

100% Dormant

Spectron Services Limited

155 Bishopsgate, London,

EC2M 3TQ

England and

Wales

Ordinary

shares

100% Facilities services

1 Marex Spectron International Limited operates branches in the following countries:

▪ Canada – Suite 400, 4th Floor, 110-9th Avenue SW, Calgary, Alberta, Canada

▪ Germany – Romerstrass 31 , 63486 Bruchkobel, Frankfurt

▪ Norway – Kronprinsesse Marthas Plass 1, 0160 Oslo, Norge

▪ United States of America – 360 Madison Ave, Third Floor, New York 10017

Page 59: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

58

16. INVESTMENTS (CONTINUED)

(c) Group subsidiaries and undertakings (continued)

Subsidiaries held indirectly

Name / Registered office

Country of

incorporation

/ Principal

place of

business Class

Proportion

of

ownership

interest

Nature of

business

Carlton Commodities 2004 LLP

155 Bishopsgate, London, EC2M

3TQ

England and

Wales

Partnership

interest

N/A Commodity and

option trading

Marex Spectron Asia Pte Limited

8 Marina Way, 33-06 Asia Tower

1, Singapore, 018960

Singapore Ordinary

shares

100% Freight broking

Marex Spectron Inc.

360 Madison Ave, Third Floor,

New York 10017

United States of

America

Ordinary

shares

100% Dormant

Marex Spectron Ltd

20/F Alexandra House, 16-20

Chater Road, Central, Hong Kong

Hong Kong Ordinary

shares

100% Dormant

Marex Spectron Pte Ltd

8 Marina Way, 33-06 Asia Tower

1, Singapore, 018960

Singapore Ordinary

shares

100% Dormant

Marex Spectron Securities LLP

155 Bishopsgate, London, EC2M

3TQ

England and

Wales

Partnership

interest

N/A Dormant

Marex Trading Services (Gibraltar)

Limited

Steadfast Corporate Services

Limited, 19A town Range, P.O.

Box 872, Gibraltar

Gibraltar Ordinary

shares

100% Dormant

Nanolytics Capital Advisors

Limited

155 Bishopsgate, London, EC2M

3TQ

England and

Wales

Ordinary

shares

100% Appointed

representative

of a fund

management

company

Spectron Energy Asia Pte Limited

8 Marina Way, 33-06 Asia Tower

1, Singapore, 018960

Singapore Ordinary

shares

100% Energy OTC

broking

Spectron Energy Inc.

360 Madison Ave, Third Floor,

New York 10017

United States of

America

Ordinary

shares

100% Energy OTC

broking

Xeram SA

Walder Wyss Avocats, Rue

d’Italie 10, 1204 Genève

Switzerland Ordinary

shares

100% Dormant

All subsidiaries have a financial year end of 31 December with the exception of Carlton Commodities 2004

LLP and Marex Spectron Securities LLP which have a year end of 31 March.

Page 60: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

59

16. INVESTMENTS (CONTINUED)

(c) Group subsidiaries and undertakings (continued)

Other Related Entities

Name

Country of

incorporation Class

Proportion

of

ownership

interest

Nature of

business

Elian Employee Benefit Trustee

Limited, 44 Esplanade St Helier

Jersey, JE4 9WG

Channel Islands Ordinary

shares

Nil Trustee of the

employee

benefit trust

17. INVENTORY

The Group holds physical metal, in the form of London Metal Exchange warrants, measured at fair value.

These are generally held on a short-term basis.

18. OTHER ASSETS – NON-CURRENT

Non-current other assets relate to deferred proceeds from the sale of Eclipse Energy Holdings SA, which is

to be released from escrow on or before 3 January 2017.

As at 31 December 2016 these proceeds are due within one year and have been recognised as a current asset

under trade and other receivables.

19. SUBORDINATED LOANS DUE TO GROUP UNDERTAKINGS

The Revolving Subordinated Loan Agreement with Marex North America LLC was renewed during the year

with the approval of the CME. The new facility has a drawing termination date of 30 September 2018,

maturity date of 30 September 2021 and total credit line of $55,000,000 (2015: $45,000,000). The

subordinated borrowings of $17,500,000 (2015: $9,000,000) are unsecured and carry interest at the daily

three-month LIBOR plus 2.75% (2015: US Prime rate plus 2.75%).

The subordinated borrowings qualify as equity capital as defined by the CFTC regulation1.17d.

20. FINANCIAL INSTRUMENTS – FAIR VALUE THROUGH PROFIT AND LOSS (NON-CURRENT)

Financial instruments at fair value through profit or loss comprise US Treasuries that were provided as a

security deposit for a leasehold property and mature on 31 July 2018.

21. FINANCIAL INSTRUMENTS – HELD TO MATURITY

Held to maturity financial instruments comprises US Treasuries with maturity dates from January 2017 to

March 2018.

During the year the Group has pledged US Treasuries to counterparties as collateral for financing

transactions. Financial instruments which have been pledged in this way are held under certain terms and

conditions set out in specific agreements with each counterparty. In these agreements it is generally stated

that whilst the US Treasury is pledged at the counterparty the Group cannot:

▪ sell or transfer the financial instrument;

▪ dispose of the financial instrument; or

▪ have any third party rights associated with the financial instrument whereby it can be used as security

towards any further financing activities.

Page 61: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

60

22. TRADE AND OTHER RECEIVABLES

Group Company

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Amounts due from exchanges, clearing

houses and other counterparties 558,848 572,156 - -

Trade debtors 21,107 19,798 - -

Default funds and deposits 42,959 42,991 - -

Amounts due from group undertakings - - 57 27,015

Loans receivable 645 849 - -

Other tax and social security taxes 1,635 2,987 - -

Other debtors 14,710 3,237 - -

Prepayments 6,397 6,381 - -

646,301 648,399 57 27,015

Included in the amounts due from exchanges, clearing houses and other counterparties are segregated

balances of $458,156,000 and non-segregated balances of $100,692,000.

Trade receivables disclosed above are classified as loans and receivables and, therefore, measured at

amortised cost with the exception of amounts due from exchanges, clearing houses and other counterparties

of $166,622,729 (2015: $279,906,000) which are classified as fair value through profit or loss.

Included in other debtors is $7,088,313 (2015: $827,000) which is due in more than one year, relating to

sign-on bonuses which are awarded to employees and amortised over the term of the contract.

Amounts due from exchanges, clearing houses and other counterparties and trade debtors are stated after

deducting impairment provisions of $1,299,000 (2015: $4,949,000).

(a) Ageing of past due, but not impaired, receivables

Group

2016

$’000

2015

$’000

Less than 30 days 5,272 4,455

31 to 60 days 1,846 1,793

61 to 90 days 701 1,161

91 to 120 days 449 394

More than 120 days 1,452 1,863

9,720 9,666

Page 62: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

61

22. TRADE AND OTHER RECEIVABLES (CONTINUED)

(b) Reconciliation of the movement in provisions for bad and doubtful debts

Group

Notes

2016

$’000

2015

$’000

As at 1 January 4,949 4,889

Charged to the consolidated income

statement 6 126 46

Bad debts written off (3,778) -

Foreign exchange revaluation 2 14

At 31 December 1,299 4,949

The directors consider that the carrying amount of trade and other receivables is approximately equal to their

fair value.

23. SHORT-TERM BORROWINGS

Group

2016

$’000

2015

$’000

Unsecured borrowing at amortised cost

Bank overdraft 5,000 -

Revolving credit facility 35,000 -

40,000 -

The Group has an annually committed credit agreement with a current revolving loan facility of up to

$65,000,000 with a renewal date of 5 June 2017. As at 31 December 2016, $35,000,000 of the facility has

been utilised.

The credit agreement contains certain financial and other covenants. The Group was in compliance with all

applicable covenants throughout the year. Interest on the amount utilised is charged at LIBOR + 250 basis

points and on the unutilised portion at 100 basis points.

Page 63: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

62

24. DERIVATIVE INSTRUMENTS

Derivative assets and derivative liabilities at fair value through profit or loss comprise of over-the-counter

foreign exchange and precious metal contracts. These are entered to hedge over-the-counter foreign

exchange and precious metal contracts transacted between the Group and their customers.

Group

2016

$’000

2015

$’000

Financial assets carried at fair value through profit

or loss (‘FVTPL’)

Held for trading derivatives that are not designated in

hedge accounting relationships:

Forward foreign currency contracts 2,167 1,114

Foreign currency options 58 -

Precious metal forward contracts 21,787 3,822

Precious metal option contracts - -

24,012 4,936

Group

2016

$’000

2015

$’000

Financial liabilities carried at fair value through

profit or loss (‘FVTPL’)

Held for trading derivatives that are not designated in

hedge accounting relationships:

Forward foreign currency contracts 5,104 2,262

Foreign currency options 44 -

Precious metal forward contracts 6,787 1,280

Precious metal option contracts 92 -

12,027 3,542

Page 64: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

63

25. DEFERRED TAX

Group Company

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Revaluation of investments – available-

for-sale (411) (515) 120 111

Depreciation in excess of capital

allowances 1,815 1,856 - -

Tax losses 3,299 3,875 - -

Other 56 74 - -

31 December 4,759 5,290 120 111

Group Company

2016

$’000

2015

$’000

2016

$’000

2015

$’000

At 1 January 5,290 477 111 (201)

(Charged) / credited to the income

statement (note 11(a)) (635) 4,435 - -

Credited to other comprehensive income 104 379 10 312

Foreign exchange differences and other - (1) (1) -

31 December 4,759 5,290 120 111

Deferred tax assets and liabilities are offset where the Group has a legally enforceable right to do so.

The reduction in the main rate of UK corporation tax to 20% from 1 April 2015 was substantively enacted on

2 July 2013. Deferred tax balances have been calculated at the effective tax rate ruling at the balance sheet

date. Finance (No. 2) Act 2015 enacted reductions in the UK corporation tax rate to 19% with effect from 1

April 2017 and 18% with effect from 1 April 2020. Finance Act 2016 enacted a further reduction in the UK

corporation tax rate to 17% by 2020.

The reduction of the UK corporation tax rate to 19% has been recognised in the deferred tax charge and

closing deferred tax position. However, the subsequent reduction to 17% from April 2020 has not been

recognised in the deferred tax charge and closing deferred tax position as its impact is not material.

(a) Unrecognised deferred tax assets

The Group has unrecognised deferred tax assets in respect of:

▪ employee compensation deductions of $4,445,000 (2015: $5,306,000). The potential deferred tax asset

at 17% (2015: 20%) is $756,000 (2015: $1,061,000). These assets have not been recognised as it is not

foreseeable when a tax deduction will arise; and

▪ tax losses of $11,240,000 (2015: $11,013,000). Of this amount, $11,240,000 (2015: $11,013,000)

relates to losses with no expiry date. Losses of $1,010,000 (2015: $246,000) are subject to approval by

the relevant tax authorities. These assets are not recognised on the basis of insufficient evidence

concerning profits being available against which deferred tax assets could be utilised.

Page 65: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

64

26. TRADE AND OTHER PAYABLES

Group Company

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Amounts due to exchanges, clearing

houses and other counterparties 647,327 632,770 - -

Amounts due to group undertakings - - 1,620 -

Other tax and social security taxes 1,480 1,852 - -

Other creditors 1,400 8,191 - 643

Accruals and deferred income 57,373 63,937 257 196

707,580 706,750 1,877 839

Included in the amounts due to exchanges, clearing houses and other counterparties are segregated balances

of $458,117,000 and non-segregated balances of $189,210,000. Included in the non-segregated balance of

$189,210,000 is $42,556,078 which is classified as fair value through profit or loss.

The directors consider that the carrying amount of trade and other payables is approximately equal to their

fair value.

27. PROVISIONS

Group

Onerous

lease

$’000

Leasehold

dilapida-

tions

$’000

Total

$’000

Non-current

At 1 January 2016 196 1,217 1,413

Movement in the year:

Credited during the year (note 9) (4) (876) (880)

Utilised during the year (192) (24) (216)

Foreign exchange valuation - (52) (52)

(196) (952) (1,148)

At 31 December 2016 - 265 265

Onerous lease provisions relate to the excess of rent payable over rents receivable on sublet office space.

Inherent uncertainties in measuring the provision relate to estimates of the amount of rent that will be

received in the future on vacant property and estimating future rents on property where the current sublease

is of a shorter duration than the head lease. The provision was utilised during the year with no further

uncertainties to recognise in the current period.

Leasehold dilapidations relate to the estimated cost of returning a leasehold property to its original state at

the end of the lease in accordance with the lease terms. The main uncertainty relates to estimating the cost

that will be incurred at the end of the lease. The provision was released during the year upon renegotiation

of the lease agreement. The new lease agreement terminates 22 March 2027.

Page 66: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

65

28. SHARE CAPITAL

Group and Company

Issued and fully paid Issued and fully paid

2016

Number

2016

$’000

2015

Number

2015

$’000

Ordinary shares of $0.000165 each 106,491,588 18 106,491,588 18

Non-voting ordinary shares of

$0.000165 each

3,986,376

1

3,986,376

1

Deferred shares of $1.65 each 106,798,427 176,217 106,798,427 176,217

Growth shares of $0.000165 each 13,981,025 2 14,164,766 2

231,257,416 176,238 231,441,157 176,238

Group and Company

Ordinary

shares

Number

Non-voting

ordinary

shares

Number

Deferred

shares

Number

Growth

shares

Number

Total

Number

At 1 January 2016 106,491,588 3,986,376 106,798,427 14,164,766 231,441,157

Shares cancelled during

the year - - - (183,741) (183,741)

At 31 December 2016 106,491,588 3,986,376 106,798,427 13,981,025 231,257,416

Growth shares of $183,741 were cancelled during the year following the resignation of a director of the

Group.

Page 67: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

66

28. SHARE CAPITAL (CONTINUED)

The rights of the shares are as follows:

Class of share Rights

Ordinary shares Full voting rights and right to participate in ordinary dividends ranking

pari passu with non-voting ordinary shares. In the event of a winding

up, entitled to a return of capital ranking pari passu with non-voting

ordinary shares and no right of redemption.

Non-voting ordinary shares As per ordinary shares, other than having no voting rights.

Deferred shares No voting rights, no right to participate in dividends and no right to

redemption. In the event of a winding up, entitled to a return of capital

ranking pari passu with ordinary shares for any capital in excess of £50

billion.

Growth shares No voting rights, no rights to participate in dividends, no entitlement to

participate in winding up and no right of redemption.

In 2010, 2012 and 2015 the Group issued growth shares to 18 individuals,

which entitle the holders to a share of the proceeds from a ‘liquidity

event’, such as an Initial Public Offering or a sale, if the proceeds

exceeded some specific level thereby diluting existing ordinary

shareholders. The holders of growth awards are not entitled to receive

dividends nor do they have voting rights and cannot impact the timing of

a transaction.

The growth shares vest over 3 to 5 years, but do not expire. The growth

awards can be settled through the issuance of ordinary shares, whereby

the Company issues the growth award holder a number of ordinary

shares equal in value to the growth award amount, or in cash.

The directors’ view is that it is currently probable the growth awards will

be settled in shares and, therefore, they are treated as equity-settled share

based payments.

29. RESERVES

The following describes the nature and purpose of each reserve within total equity:

Reserves Description

Share capital Amount subscribed for share capital at nominal value.

Share premium Amount of consideration received over and above the par value of shares.

Retained earnings Cumulative net gains and losses recognised in the income statement or

statement of other comprehensive income.

Revaluation reserve Cumulative unrealised gains on investments in exchanges that are held as

available-for-sale and recognised in equity.

Other reserves Foreign currency translation reserve.

Page 68: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

67

30. LEASE COMMITMENTS

The Group has entered into commercial leases on its properties.

The lessee has the options of renewal on each of these leases subject to negotiation between the Group, as

lessee, and each landlord in the period preceding the expiration of each lease. There were no restrictions

placed upon the lessee by entering into these leases.

Group

Notes

2016

$’000

2015

$’000

Lease payments under operating leases

recognised as an expense in the year 6 7,335 10,412

The total future minimum lease payments are due as follows:

Group

2016

$’000

2015

$’000

Within one year 6,393 8,190

In the second to fifth years inclusive 13,794 9,726

After five years 470 -

20,657 17,916

The total sublease receipts included in the income statement during the year is $1,949,074 (2015: $331,844).

The total future minimum sublease receipts are due as follows:

Group

2016

$’000

2015

$’000

Within one year 412 332

In the second to fifth years inclusive 1,537 -

1,949 332

Page 69: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

68

31. FINANCIAL INSTRUMENTS

(a) Capital risk management

For the purpose of the Group’s capital management, capital includes issued share capital, share premium and

all other equity reserves attributable to the equity holders of the parent as disclosed in notes 28 and 29. The

primary objective of the Group’s capital management is to maximise the shareholder value.

In order to achieve this overall objective, the Group’s capital management, amongst other things, aims to

ensure that it meets financial covenants attached to the interest-bearing loans and borrowings that define

capital structure requirements. Breaches in meeting the financial covenant would permit the bank to

immediately call loans and borrowings. There have been no breaches in the financial covenants of any

interest-bearing loans and borrowing in the current year.

Many of the Group’s material operating subsidiaries are subject to regulatory restrictions and minimum

capital requirements. At 31 December 2016, each of these subsidiaries had net capital in excess of the

requisite minimum requirements.

No changes were made in objectives, policies or processes for managing capital during the year.

(b) Categories of financial instruments

Some of the Group’s assets are carried at fair value or contract amounts that approximate fair value.

Set out, below, is an analysis of the categories of financial instruments. Due to the nature of the underlying

assets, the carrying value approximates fair value.

Group Company

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Financial assets:

Cash and cash equivalents 188,178 158,261 486 116

188,178 158,261 486 116

At fair value through the income

statement:

Inventory - 15,870 - -

Amounts due from exchanges, clearing

houses and other counterparties 166,623 279,906 - -

Financial instruments – fair value through

profit or loss 653 658 - -

Derivative instruments 24,012 4,936 - -

191,288 301,370 - -

Page 70: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

69

31. FINANCIAL INSTRUMENTS (CONTINUED)

(b) Categories of financial instruments (continued)

Group Company

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Available-for-sale at fair value through

other comprehensive income:

Investments 6,896 7,261 3,134 3,165

6,896 7,261 3,134 3,165

Held-to-maturity investments:

Financial instruments – held to maturity 120,209 119,524 - -

120,209 119,524 - -

Loans and receivables

Amounts due from exchanges, clearing

houses and other counterparties 392,225 292,250 - -

Other assets - 908 - -

Trade debtors 21,107 19,798 - -

Default funds and deposits 42,959 42,991 - -

Amounts due from group undertakings - - 57 27,015

Loans receivable 645 849 - -

Other tax and social security taxes 1,635 2,987 - -

Other debtors 3,523 3,237 - -

Subordinated loans due to group

undertakings - - 17,500 9,000

462,094 363,020 17,557 36,015

968,665 949,436 21,177 39,296

Page 71: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

70

31. FINANCIAL INSTRUMENTS (CONTINUED)

(b) Categories of financial instruments (continued)

Group Company

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Financial liabilities

At fair value through the income

statement:

Amounts due to exchanges, clearing

houses and other counterparties 42,556 - - -

Derivative instruments 12,027 3,542 - -

54,583 3,542 - -

At amortised cost:

Amounts due to exchanges, clearing

houses and other counterparties 604,771 632,770 - -

Amounts due to group undertakings - - 1,620 -

Other tax and social security taxes 1,480 1,852 - -

Other creditors 1,400 8,191 - 643

Accruals and deferred income 57,373 63,937 257 196

Repurchase agreements - 18,938 - -

Short-term borrowings 40,000 - - -

Provisions 265 1,413 - -

705,289 727,101 1,877 839

759,872 730,643 1,877 839

Page 72: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

71

31. FINANCIAL INSTRUMENTS (CONTINUED)

(c) Financial instruments subject to offsetting, enforceable master netting arrangements and similar

agreements

As a member of the LME, the Group is subject to the settlement and margining rules of LME Clear. The

majority of products transacted by the Group are LME forward contracts. LME forwards that are in-the-

money do not settle in cash until maturity (‘prompt’) date, while the firm is required to post margin to cover

loss-making contracts daily. In accordance with the LME Clear rules, the Group is able to utilise forward

profits to satisfy daily margin requirements and are set-off against loss-making contracts. Consequently,

amounts due from exchanges, clearing houses and other counterparties are presented on a net basis in the

balance sheet.

The effect of offsetting is disclosed, below:

Group

31 December 2016

Gross

amount

$’000

Amounts

set-off

$’000

Net

amount

presented

$’000

Non-cash

collateral

rec’d /

(pledged)

$’000

Cash

collateral

rec’d /

(pledged)

$’000

Net

amount

$’000

Financial assets

Amounts due from

exchanges, clearing houses

and other counterparties 1,489,641 (930,793) 558,848 - - 558,848

Financial liabilities

Amounts due to exchanges,

clearing houses and other

counterparties 1,578,120 (930,793) 647,327 (84,145) - 563,182

Group

31 December 2015

Gross

amount

$’000

Amounts

set-off

$’000

Net

amount

presented

$’000

Non-cash

collateral

rec’d /

(pledged)

$’000

Cash

collateral

rec’d /

(pledged)

$’000

Net

amount

$’000

Financial assets

Amounts due from

exchanges, clearing houses

and other counterparties 1,091,640 (519,484) 572,156 - - 572,156

Financial liabilities

Amounts due to exchanges,

clearing houses and other

counterparties 1,152,254 (519,484) 632,770 (68,589) - 564,181

Page 73: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

72

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives

The Group’s activities expose it to a number of financial risks including market risk, operational risk, credit

risk and liquidity risk as discussed in the strategic report.

The Group manages these risks through various control mechanisms and its approach to risk management is

both prudent and evolving.

Overall responsibility for risk management rests with the Board. Dedicated resources within the Risk

Department control and manage the exposures of the Group’s own positions, the positions of its clients and

its exposures to its counterparties as well as operational exposures, within the risk appetite set by the Board.

Credit risk

The maximum credit risk exposure relating to financial assets is represented by the carrying value as at the

balance sheet date. Credit risk in the Group principally arises from cash and cash equivalents deposited with

third party institutions, exposures from transactions and balances with exchanges and clearing houses, and

exposures resulting from transactions and balances relating to customers and counterparties, some of which

have been granted credit lines.

The Group only makes treasury deposits with banks and financial institutions that have received approval

from the Group’s Executive Credit Risk Committee. These deposits are also subject to counterparty limits

with respect to concentration and maturity.

The Group’s exposure to customer and counterparty transactions and balances is managed through the

Group’s credit policies and, where appropriate, the use of initial and variation margin credit limits in

conjunction with overall position limits for all customers and counterparties. These exposures are monitored

both intraday and overnight. The limits are set by the Group’s Credit Risk Committee through a formalised

process.

The maximum credit risk exposure relating to financial assets is represented by the carrying value as at the

balance sheet date.

Page 74: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

73

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Credit quality

The table below does not take into account collateral held.

Group Company

2016

$’000

2015

$’000

2016

$’000

2015

$’000

AA and above 65,437 85,962 - -

AA- 290,814 233,780 486 116

A+ 34,349 42,471 - -

A 193,223 177,825 - -

A- 9,767 2,772 - -

BBB+ 1,301 3,438 - -

Lower and unrated 373,774 403,188 20,691 39,180

968,665 949,436 21,177 39,296

Group Company

Financial assets

2016

$’000

2015

$’000

2016

$’000

2015

$’000

Investments – available-for-sale 6,896 7,261 3,134 3,165

Other assets - 908 - -

Financial instruments – held to maturity 120,209 119,524 - -

Financial instruments – fair value through

profit or loss 653 658 - -

Inventory - 15,870 - -

Derivative assets 24,012 4,936 - -

Amounts due from exchanges, clearing

houses and other counterparties 558,848 572,156 - -

Trade debtors 21,107 19,798 - -

Default funds and deposits 42,959 42,991 - -

Amounts due from group undertakings - - 57 27,015

Loans receivable 645 849 - -

Other debtors 3,523 3,237 - -

Cash and cash equivalents 188,178 158,261 486 116

Other tax and social security taxes 1,635 2,987 - -

Subordinated loans due to group

undertakings - - 17,500 9,000

968,665 949,436 21,177 39,296

Page 75: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

74

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Credit quality (continued)

The Group has received collateral of $8,636,349 (2015: $nil) in respect of its derivative assets. The

collateral has been recognised in the amounts due to exchanges, clearing houses and other counterparties as

at 31 December 2016.

Market risk

The Group’s activities expose it to financial risks primarily generated through foreign exchange, interest rate

and commodity market price exposures which are outlined in the strategic report.

Market risk sensitivity

As principally an intermediary, the Group’s market risk exposure is modest. It manages this market risk

exposure using appropriate risk management techniques within pre-defined and independently monitored

parameters and limits.

The Group uses a range of tools to monitor and limit market risk exposures. These include Value-at-Risk

(‘VaR’), sensitivity analysis and stress testing.

Value at risk (‘VaR’)

VaR is a technique that estimates the potential losses that could occur on risk positions as a result of

movements in market rates and prices over a specified time horizon and to a given level of confidence.

The VaR model used by the Group is based upon the Monte Carlo simulation technique. This model derives

plausible future scenarios from past series of recorded market rates and prices, taking account of inter-

relationships between different markets and rates, including interest rates and foreign exchange rates. The

model also incorporates the effect of option features on the underlying exposures.

The Monte Carlo simulation model used by the Group incorporates the following features:

▪ 5,000 simulations using a variance covariance matrix;

▪ simulations generated using geometric Brownian motion;

▪ an exceptional decay factor is applied across an estimation period of 250 days; and

▪ VaR is calculated to a 1-day, 99.75% one tail confidence level.

The Group validates VaR by comparing to alternative risk measures, for example, scenario analysis and

exchange initial margins as well as the back testing of calculated results against actual profit and loss.

Although a valuable guide to risk, VaR should always be viewed in the context of its limitations, for

example:

▪ the use of historical data as a proxy for estimating future events may not encompass all potential

events, particularly those which are extreme in nature;

▪ the use of a 1-day holding period assumes that all positions can be liquidated or hedged in 1-day. This

may not fully reflect the market risk arising at times of severe liquidity stress, when a 1-day holding

period may be insufficient to liquidate or hedge all positions fully;

▪ the use of a 99.75% confidence level, by definition, does not take into account losses that might occur

beyond this level of confidence;

▪ the VaR, disclosed below, is calculated on the basis of exposures outstanding at the close of business

and, therefore, does not necessarily reflect intra-day exposure; and

▪ VaR is unlikely to reflect loss potential on exposures that only arise under significant market moves.

Page 76: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

75

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Value at risk (‘VaR’)

The Group recognises these limitations by augmenting its VaR limits with other position and sensitivity limit

structures. The Group also applies a wide range of stress testing, both on individual portfolios and on the

Group’s consolidated positions. The VaR as at 31 December 2016 was $1,135,273 (2015: $662,000) and the

average monthly VaR for the year ended 31 December 2016 was $1,183,237 (2015: $1,091,000).

Foreign currency risk

As the majority of the revenue generated, and asset and liabilities of the Group are in US Dollars, there is

minimal exposure to structural currency risk. Management monitors currency exposure on a daily basis and

buys or sells currency to minimise the exposure.

Foreign exchange sensitivity

The majority of the Group’s net assets are in US Dollars which minimises the effect exchange rate

fluctuations will have on overall net assets.

Interest rate risk

The Group is exposed to interest rate risk on cash, investments, derivatives, client balances and bank

borrowings.

The main interest rate risk is derived from interest-bearing deposits in which the Group invests surplus funds

and bank borrowings.

The Group’s exposure to interest rate fluctuations is limited through the offset that exists between the bulk of

its interest bearing assets and interest bearing liabilities. Since the return paid on client liabilities is generally

reset to prevailing market interest rates on an overnight basis, the Group is only exposed for the time it takes

to reset its investments which are held at rates fixed for a maturity which does not exceed three months, with

the exception of US Treasuries which have a maturity of up to two years.

Operational risk

Operational risk is the risk of loss arising through failures associated with personnel, processes or systems, or

from external events. It is inherent in every business organisation and covers a wide spectrum of issues.

Operational risk is managed through systems and procedures in which processes are documented,

authorisation is independent, and transactions are monitored and reconciled.

The Group maintains disaster recovery or contingency facilities to support operations and ensure business

continuity. The invocation of these facilities is regularly tested.

Compliance or Regulatory risk arises from a failure or inability to comply with the laws, regulations or codes

applicable specifically to the Group. Non-compliance can lead to fines, public reprimands, enforced

suspensions of services, or in extreme cases, withdrawal of authorisation to operate.

Companies within the Group are subject to authorisation by the LME, the CME Group of exchanges, NLX,

DGCX, London Stock Exchange, ICE US, NYSE Liffe, ICE Futures and Eurex. The Group is regulated in

the UK by the FCA (which regulates the Group under consolidated supervision), in the US by the NFA and

CFTC, in Hong Kong by the SFC, and in Singapore by the MAS and IES.

Geographical risk arises from the physical separation of some elements of the Group from the central control

locations. Internal control failure is the risk arising from the inadequacy or breakdown of critical internal

control processes.

Page 77: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

76

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Concentration risk

In order to avoid excessive concentrations of risk with respect to bank counterparties, the Group maintains a

diversified portfolio of cash accounts in accordance with the Board’s risk appetite.

To mitigate the concentration of credit risk exposure to a particular single customer, counterparty or group of

affiliated customers or counterparties, the Group monitors these exposures carefully and ensures that these

remain within pre-defined limits. Large exposure limits are determined in accordance with appropriate

regulatory rules.

Further concentration risk controls are in place to limit exposure to clients or counterparties within single

countries of origin and operation through specific country credit risk limits as set by the Board Risk

Committee.

The largest concentration of cash balances as at 31 December 2016 was 74% (2015: 82%) to a UK-based,

AA- rated global banking group (2015: UK-based, AA- rated global banking group).

The largest concentration of exposures to exchanges, clearing houses and other counterparties as at 31

December 2016 was 30% (2015: 49%) to a non-rated global clearing house (2015: non-rated global clearing

house).

Liquidity risk

The Group defines liquidity risk as the failure to meet its day-to-day capital and cash flow requirements.

Liquidity risk is assessed and managed under the Individual Liquidity Adequacy Assessment (‘ILAA’) and

Liquidity Risk Framework. To mitigate liquidity risk, the Group has implemented robust cash management

policies and procedures that monitor liquidity daily to ensure that the Group has sufficient resources to meet

its margin requirement at clearing houses and third party brokers. In the event of a liquidity issue arising, the

Group has recourse to existing global cash resources after which it could draw down on a $30 million

committed revolving credit facility as an additional contingency funding.

There are strict guidelines followed in relation to products and duration into which excess liquidity can be

invested. Excess liquidity is invested in highly liquid instruments, such as cash deposits with financial

institutions for a period of less than three months and US Treasuries with a maturity of up to two years.

The financial liabilities are based upon rates set on a daily basis, apart from the financing of the warrant

positions and the credit facility where the rates are set for the term of the loan. For assets not marked-to-

market there is no material difference between the carrying value and fair value.

Page 78: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

77

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Liquidity risk (continued)

Liquidity risk exposures

The following table details the Group’s expected undiscounted contractual maturity for non-derivative

financial liabilities:

Group

On demand

$’000

Less than 3

months

$’000

3 to 12

months

$’000

1 to 5

years

$’000

Total

$’000

Amounts due to

exchanges, clearing

houses and other

counterparties 647,327 - - - 647,327

Other tax and social

security taxes - 1,480 - - 1,480

Other creditors - 1,400 - - 1,400

Accruals and deferred

income - 52,438 4,601 334 57,373

Short-term borrowings - 40,000 - - 40,000

At 31 December 2016 647,327 95,318 4,601 334 747,580

Group

On demand

$’000

Less than 3

months

$’000

3 to 12

months

$’000

1 to 5

years

$’000

Total

$’000

Amounts due to

exchanges, clearing

houses and other

counterparties 632,770 - - - 632,770

Other tax and social

security taxes - 1,852 - - 1,852

Other creditors - 8,191 - - 8,191

Accruals and deferred

income - 59,831 4,106 - 63,937

Repurchase agreements - 18,938 - - 18,938

At 31 December 2015 632,770 88,812 4,106 - 725,688

Page 79: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

78

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Liquidity risk (continued)

Company

On demand

$’000

Less than 3

months

$’000

3 to 12

months

$’000

1 to 5

years

$’000

Total

$’000

Amounts due to group

undertakings 1,620 - - - 1,620

Accruals and deferred

income - 257 - - 257

At 31 December 2016 1,620 257 - - 1,877

Company

On demand

$’000

Less than 3

months

$’000

3 to 12

months

$’000

1 to 5

years

$’000

Total

$’000

Other creditors - 643 - - 643

Accruals and deferred

income - 196 - - 196

At 31 December 2015 - 839 - - 839

Page 80: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

79

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Liquidity risk (continued)

Shown below is the Group’s expected undiscounted contractual maturity for non-derivative financial assets:

Group

On demand

$’000

Less than 3

months

$’000

3 to 12

months

$’000

1 to 5

years

$’000

Total

$’000

Amounts due from

exchanges, clearing

houses and other

counterparties 558,848 - - - 558,848

Trade debtors - 21,107 - - 21,107

Default funds and

deposits - 42,959 - - 42,959

Loans receivable 436 11 198 - 645

Other debtors - 3,281 18 224 3,523

Cash and cash equivalents 188,178 - - - 188,178

Other tax and social

security taxes - 1,635 - - 1,635

At 31 December 2016 747,462 68,993 216 224 816,895

Group

On demand

$’000

Less than 3

months

$’000

3 to 12

months

$’000

1 to 5

years

$’000

Total

$’000

Amounts due from

exchanges, clearing

houses and other

counterparties 572,156 - - - 572,156

Other assets - - - 908 908

Trade debtors 19,798 - - - 19,798

Default funds and

deposits - 42,991 - - 42,991

Loans receivable 544 13 292 - 849

Other debtors - 328 198 11 537

Cash and cash equivalents 158,261 - - - 158,261

Inventory - 15,870 - - 15,870

Other tax and social

security taxes - 2,987 - - 2,987

At 31 December 2015 750,759 62,189 490 919 814,357

Page 81: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

80

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Liquidity risk (continued)

Company

On demand

$’000

Less than 3

months

$’000

3 to 12

months

$’000

1 to 5

years

$’000

Total

$’000

Amounts due from group

undertakings 57 - - - 57

Cash and cash equivalents 486 - - - 486

Subordinated loans due to

group undertakings - - - 17,500 17,500

At 31 December 2016 543 - - 17,500 18,043

Company

On demand

$’000

Less than 3

months

$’000

3 to 12

months

$’000

1 to 5

years

$’000

Total

$’000

Amounts due from group

undertakings 27,015 - - - 27,015

Cash and cash equivalents 116 - - - 116

Subordinated loans due to

group undertakings - - - 9,000 9,000

At 31 December 2015 27,131 - - 9,000 36,131

Both assets and liabilities are included to understand the Group’s liquidity risk management as the liquidity

is managed on a net asset and liability basis.

Page 82: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

81

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Liquidity risk (continued)

The following table details the Group’s expected contractual maturity for derivative financial assets and

derivative financial liabilities:

Group

On demand

$’000

Less than 3

months

$’000

3 to 12

months

$’000

1 to 5

years

$’000

Total

$’000

Derivative instruments -

assets - 23,216 442 354 24,012

Derivative instruments -

liabilities - (11,901) (120) (6) (12,027)

At 31 December 2016 - 11,315 322 348 11,985

Group

On demand

$’000

Less than 3

months

$’000

3 to 12

months

$’000

1 to 5

years

$’000

Total

$’000

Derivative instruments -

assets - 4,711 225 - 4,936

Derivative instruments -

liabilities - (2,982) (327) (233) (3,542)

At 31 December 2015 - 1,729 (102) (233) 1,394

Page 83: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

82

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Fair value measurement

The information set out below provides information about how the Group determines fair values of various

financial assets and financial liabilities.

The following table provides an analysis of financial instruments that are measured subsequent to initial

recognition at fair value, grouped into Levels 1 to 3 based on the degree to which the fair value is observable:

▪ Level 1 fair value measurements are those derived from quoted prices (unadjusted) in active markets

for identical assets or liabilities;

▪ Level 2 fair value measurements are those derived from inputs other than quoted prices included within

Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e.

derived from prices); and

▪ Level 3 fair value measurements are those derived from valuation techniques that include inputs for the

asset or liability that are not based on observable market data (unobservable inputs).

The level 2 pricing for investments is based on the latest traded price. The level 2 pricing for derivative

instruments is based on counterparty information which provides daily valuations.

The following table shows an analysis of the financial assets and liabilities recorded at fair value shown in

accordance with the fair value hierarchy.

Group

Level 1

$’000

Level 2

$’000

Level 3

$’000

Total

$’000

Financial assets at FVTPL:

Amounts due from exchanges, clearing

houses and other counterparties 166,623 - - 166,623

Financial instruments – fair value through

profit or loss 653 - - 653

Derivative instruments - 24,012 - 24,012

Available-for-sale financial assets

Investments 1,901 4,995 - 6,896

Financial liabilities at FVTPL:

Amounts due to exchanges, clearing

houses and other counterparties (42,556) - - (42,556)

Derivative instruments - (12,027) - (12,027)

At 31 December 2016 126,621 16,980 - 143,601

Page 84: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

83

31. FINANCIAL INSTRUMENTS (CONTINUED)

(d) Financial risk management objectives (continued)

Fair value measurement (continued)

Group

Level 1

$’000

Level 2

$’000

Level 3

$’000

Total

$’000

Financial assets at FVTPL:

Inventory 15,870 - - 15,870

Amounts due from exchanges, clearing

houses and other counterparties 279,906 - - 279,906

Financial instruments – fair value through

profit or loss 658 - - 658

Derivative instruments - 4,936 - 4,936

Available-for-sale financial assets

Investments 1,603 5,658 - 7,261

Financial liabilities at FVTPL:

Derivative instruments - (3,542) - (3,542)

At 31 December 2015 298,037 7,052 - 305,089

32. CLIENT MONEY

As required by the UK FCA’s Client Assets Sourcebook rules and the CFTC’s client money rules, the Group

maintains certain balances on behalf of clients with banks, exchanges, clearing houses and brokers in

segregated accounts. These amounts and the related liabilities to clients, whose recourse is limited to

segregated accounts, are not included in the statement of financial position as the Group is not beneficially

entitled thereto.

Group

2016

$’000

2015

$’000

Segregated assets at banks

(not recognised) 447,326 396,325

Segregated assets at exchanges, clearing

houses and other counterparties

(recognised) 465,318 466,800

912,644 863,125

Page 85: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

84

33. COMPANY PROFIT AND LOSS

As permitted by section 408 of the Companies Act 2006, the Company has elected not to present its income

statement for the year. The Company reported a profit for year ended 31 December 2016 of $992,938 (2015:

$48,495,000).

34. EVENTS AFTER THE BALANCE SHEET DATE

The Group announced a $10 million receivables finance facility with RBS, effective from 13 February 2017.

There are no other significant events subsequent to the reporting date.

35. RELATED PARTY TRANSACTIONS

(a) Parent and ultimate controlling party

In these financial statements of the Group, being the Company and its subsidiaries, subsidiaries refer to the

entities controlled by the Company as disclosed in note 16(c).

In the directors’ opinion, the immediate parent and ultimate controlling party of the Company is Amphitryon

Limited, a company incorporated in Jersey, Channel Islands.

(b) Key Management Personnel

The remuneration paid to directors for their services to the Group was as follows:

Group

2016

$’000

2015

$’000

Aggregate wages and salaries 7,158 4,367

Short-term monetary benefits 71 27

7,229 4,394

The remuneration of the highest paid director for their services to the Group was $2,224,764 (2015:

$1,910,000). No pension contributions were made on their behalf whilst they were a director of the Group

(2015: $nil). No payments were made to directors in respect of loss of office (2015: $1,046,000). A loan of

$19,778 was forgiven during the year following the resignation of a director of the Group.

As at 31 December 2016, there were no directors in the Group’s defined contribution scheme (2015: nil).

The remuneration paid to other Key Management Personnel for their services to the Group was as follows:

Group

2016

$’000

2015

$’000

Aggregate wages and salaries 5,371 8,075

Short-term monetary benefits 33 64

Defined pension cost 40 46

5,444 8,185

Page 86: Annual Report and Financial Statements Year ended 31 ... - 2016... · Annual Report and Financial Statements Year ended 31 December 2016 ... (‘PBT’) of $27 million, up ... we

Marex Spectron Group Limited

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)

85

35. RELATED PARTY TRANSACTIONS (CONTINUED)

(c) Key Management Personnel transactions

The Group made loans to certain directors associated with equity awards of $141,971 (2015: $145,873). In

addition, the Group made loans to certain senior current and former employees relating to tax payments

associated with equity awards of $293,561 (2015: $795,350). The loans are non-interest bearing and will be

repayable under the terms of the equity award arising at the liquidating event.

During the year, certain employee directors of the Company were part of a long-term senior management

compensation plan arranged by the majority shareholders of the Company. The majority of the

compensation plan payable under these arrangements is contingent upon sale of the Company and the sale

price being at a level which provides all the shareholders of the Company with a profit. A minority of the

compensation plan is contingent on the profits of the Company exceeding a given threshold over a multi-year

period. The only time when the company will be required to make a payment under this plan would be when

it is sold by its shareholders.

(d) Transactions with entities having significant influence over the Group

Balances and transactions between the Company and its subsidiaries which are related parties have been

eliminated on consolidation and not disclosed in this note.

The Group pays management fees to parties associated with the ultimate parent company based on a

percentage of the Group’s profitability amounting to $767,560 (2015: $703,308).

During the year, the Group received consortium relief from entities that have significant influence over the

Group of $815,892 (2015: $1,174,000). The payable balance at 31 December 2016 was $567,660 (2015:

$7,596,000).